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I have created the first simulation of saccular aneurysm initiation and development from
a healthy artery geometry. It is capable of growing saccular aneurysm geometries from
patient-specific data. My model describes aneurysm behavior in a way that bridges fields.
I assume arteries are made of a rate-sensitive inelastic material which produces irreversible
deformation when it is overstressed. The material is assumed to consist of a 3D hyperelas-
tic background material embedded with 1D transversely-isotropic fibers. I optionally use
a Winkler foundation term to model support of external organs and distinguish healthy
tissue from diseased tissue. Lesions are defined as a local degradation of artery wall struc-
ture. My work suggests passive mechanisms of growth are insufficient for predicting sac-
cular aneurysms. Furthermore, I identify a new concept of stages of aneurysm disease.
The stages connect mathematical descriptions of the simulation with clinically-relevant
changes in the modeled aneurysm. They provide an evocative framework through which
clinical descriptions of arteries can be neatly matched with mathematical features of the
v
model. The framework gives a common language of concepts—e.g., collagen fiber, pseu-
doelastic limit, inelastic strain, and subclinical lesion—through which researchers in dif-
ferent fields, with different terminologies, can engage in an ongoing dialog: under the
model, questions in medicine can be translated into equivalent questions in mathematics.
A new stage of “subclinical lesion” has been identified, with a suggested direction for fu-
ture biomechanics research into early detection and treatment of aneurysms. This stage
defines a preclinical aneurysm-producing lesion which occurs before any artery dilatation.
It is a stage of aneurysm development involving microstructural changes in artery wall
makeup. Under the model, this stage can be identified by its reduced strength: its struc-
tural support is still within normal limits, but presumably would perform more poorly
in ex vivo failure testing than healthy tissue from the same individual. I encourage clini-
cians and biomechanicians to measure elastin degradation, and to build detailed multiscale
models of elastin degradation profiles as functions of aging and tortuosity; and similarly
for basal tone. I hope such measurements will to lead to early detection and treatment of
aneurysms. I give specific suggestions of biological tissue experiments to be performed for
improving and reinforming constitutive modeling techniques.
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Chapter 1
Introduction
Computer simulation is revolutionizing healthcare research. It has bolstered clinical di-
agnoses and treatment. It allows well-informed decisions to replace educated guesses. It
allows safe, low-cost calculations to replace expensive, risky procedures. It reduces costs
for development of new devices. It is an intersection point for collaboration, and inspires
joint institutions for translational medicine.
I have garnered the experience of physicians and engineers to provide predictive
diagnostics for the treatment of disease, so that physicians can intervene before a patient
becomes untreatable. This work is intended to build infrastructure for sharing and collab-
orative research between engineering and medicine, toward a common goal: improving
patient care.
I have developed a modeling paradigm for the creation of patient-specific geome-
tries of arteries; an analytic framework for describing the growth mechanics of aneurysms
as a fiber-based inelastic material; and, a descriptive framework for connecting clinical
features of aneurysm development with mathematical descriptions of model variables. To-
gether, they provide a predictive capability for aneurysm modeling, from patient-specific
image data to predicted outcome.
The theoretical formulation synthesizes existing concepts in the mechanics liter-
ature with novel developments in biological modeling and will provide physicians with
tools of superior accuracy and predictive value. It takes standard equations that govern the
1
Figure 1: Comparison of a subject-specific model of a human heart and a standard educational model
[Netter 2003, plate 210a]. Major differences in geometry and structure are normal. For example, the
subject has only one pulmonary vein on each side of the heart (left and right); educational models
show two on each side.
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behavior of materials that change in mass, and couples it with a biologically-viable growth
law. The entire formulation is implemented in the computational framework of isogeo-
metric analysis, using smooth geometries, ensuring accurate and stable results. Most com-
puter modeling technologies require an additional meshing step which is time-consuming,
reduces accuracy, and introduces stress singularities. [Cottrell 2009]
A portion of this work is the development of a modeling pipeline for building
accurate geometries of the heart and arteries, demonstrated in Figure 1. The heart model
in Figure 1 is a useful tool for facilitating communication between physicians, engineers,
and patients. The modeling pipeline is the basis for a general technique for modeling
organs in the body, demonstrated in Figure 3. The modeling pipeline formalizes existing
model-building techniques for the cardiovascular system and can extend tools that have
been developed for blood flow, turbulence, and solid mechanics computations.
The simulation will build on existing technologies for modeling tissue as an aniso-
tropic elastic material. Other researchers in the literature have utilized models for describ-
ing fiber-based material, including terms for growth and decay (change of mass), and a
notion of history-dependent turnover of tissue. However, a complete model for aneurysm
disease has not been formed.
A new era was introduced in [Taylor 1998], in which patient-specific engineering
simulations are run to evaluate the relative value of various possible treatments and to plan
and design the optimal intervention. The automation and improvements of the present
modeling system are necessary to provide better conclusions of the behavior and mechan-
ical nature of diseased arteries as well as improve the overall predictive capability of sim-
3
Current practice: symptom-driven healthcare  
Proposed: predictive healthcare  
time 
A case for Computational Medicine 
symptom–treatment 
loop 
Figure 2: Existing and proposed strategies for providing healthcare. Many diseases, such as aneu-
rysms and atherosclerosis, are not discovered until the disease has progressed into advanced stages.
I propose predictive systems which will alert physicians to potential problems, before damage has
occurred. Early treatments can be less costly, less invasive and have fewer side effects.
ulation tools. Physicians who use these tools will better understand aneurysm dynamics,
improve their morbidity and mortality rates, and save lives.
1.1 Broader Impact
The broader impact of this work is its ability to suggest novel tissue measurements
and facilitate collaborative analysis between physicians and engineers. Quantities com-
puted in this work can indicate risk factors for aneurysm enlargement. Current risk factors
have low predictability and high variability.
Most biological mechanisms within arteries are difficult or impossible to measure
in vivo. I suggest measurements which can be used to understand initiation of disease
and aging processes in the body. The measurements will improve researchers’ ability to
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distinguish distinct etiologies of aneurysms, by helping to classify outcomes with initial
parameters.
I created a modeling pipeline for building patient-specific artery geometries. This
is an important stepping stone for computational medicine. The ability to run predictive
simulations on patient-specific data is a crucial advance in clinical decision support. See
Figure 2.
I subdivided the computed results into distinct stages in time. The stages were
defined by mathematical properties of the constitutive model, and they neatly connect with
clinical presentations of aneurysms. One of the stages corresponds to an unrecognized
stage of disease progression.
When performing simulations, I found classes of initial data in which the com-
puted results are predictive of certain observed outcomes. By investigating the effects of
internal model variables, I can begin to form postulates/hypotheses for a physical inter-
pretation for the variables. With a physical interpretation can come biological experiments
and measurements. Specifically, I suggest careful measurement of elastin degradation pro-
files in space and time. These measurements should create advances within the medical
community for treatment and risk assessment.
1.2 Specific Aims
This work investigates specific implications of a biomechanics growth model for
aneurysms.
One investigation is to quantify and analyze force and stress distributions in un-
ruptured intracranial saccular aneurysm deformations. From a given deformation, stresses,
forces, and strains can be calculated, giving insight into the environments of aneurysms.
5
Internal parameters can be determined to give physiologically-reasonable results. They
cannot be measured in vivo, but they can be easily displayed in a simulation.
Figure 3: The author’s segmentation of thoracic or-
gans for a company seeking FDA approval. The FDA
increasingly requires computational analysis for new
technology. Included are the ribcage, lungs, heart, liver,
spleen, stomach, aorta, spinal cord, and vena cava.
I created a realistic saccu-
lar aneurysm deformation, beginning
from a healthy artery and deforming
into a diseased configuration. I com-
puted the stresses involved to effect
such a deformation. My observations
indicated the need for a supporting
force at the neck to effect a saccular
aneurysm (as opposed to a fusiform
aneurysm). I also discovered existing
constitutive models were insufficient
to describe the development of saccu-
lar aneurysms under physiologic con-
ditions. Existing constitutive models required nonphysiologic conditions.
I developed a new constitutive model for describing the disease process within
aneurysms. It uses rate-sensitive inelasticity to describe strain during disease.
I created a pipeline for building patient-specific geometries of arteries. The pipe-
line and patient-specific data helped us postulate an initial lesion.
I applied physiologic forces to the model to grow saccular aneurysm geometries
from healthy configurations. These simulations are driven by blood pressure and the pos-
tulated lesion.
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I have identified directions for future research. I suggest investigating the effect of
elastic limit profiles on aneurysm shape. I also propose tissue experiments which can be
performed to improve the models herein, and will help improve models of aging in other
tissues.
Finally, I propose the identification of stages of aneurysm disease. The stages in
this work align corresponding terminology from medicine, engineering, and mathematics.
The alignment provides a means for mathematical descriptions of medical findings. With
this it is possible to create new understanding in each field. One new clinical stage has
been identified: “subclinical lesion.” The idea will be explored with clinicians and biome-
chanicians, to improve and refine the model. For the stages to have the greatest impact,
input from many different sources should be incorporated.
1.3 Clinical background and significance
An aneurysm is a bulge in the wall of an artery, a vein, or the heart. Arterial
aneurysms occur in only a few places for reasons that are not fully understood: mainly in
the abdominal aorta and cranial arteries, especially near or on the Circle of Willis.
Aneurysms are classified into saccular aneurysms and fusiform aneurysms, de-
picted in Figure 4. Sites of diagnosed saccular aneurysms are shown in Figure 5. They
are common, life-threatening, and poorly understood. A ruptured aneurysm is often de-
bilitating or lethal. The mechanisms for enlargement and remodeling are unknown and
there exist no tests to determine which will grow or which aneurysms are stable. Imaging
aneurysms is either expensive (magnetic resonance imaging), invasive (catheterization), or
toxic (x-ray computed tomography). Routine screening is not done. Consequently, little is
known about the disease process.
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(a) Saccular aneurysm in the anterior
communicating artery (top) of the Cir-
cle of Willis. Saccular aneurysms usually
form at the flow divider of a branch; the
fibrous layer is weaker there.
(b) Physical model of a patient’s abdominal aortic an-
eurysm prior to surgery. This is an example of a
fusiform aneurysm. They often involve branch ves-
sels.
Figure 4: Distinction between aneurysms: a saccular aneurysm of the brain, and a fusiform aneurysm
of the abdominal aorta. The etiology for intracranial and abdominal aneurysms is different, but they
have an underlying principle in common: the tissue becomes weakened and subsequently bulges
outward as a result of blood pressures. This work investigates intracranial saccular aneurysms, de-
picted in (a).
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Figure 5: The most common sites of diagnosed intracranial saccular aneurysms. [Zaorsky 2011]
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In modeling aneurysms, I simulate tissue-level mechanics of artery walls. There
has been significant effort put into mechanical modeling of arteries in the past few de-
cades. It is established that arteries consist of several layers of tissues, and that the tissues
are partly composed of collagen fibers whose main (mechanical) purpose is reinforcement
of the tissue. There are, investigations have shown, multiple “families” of fibers, symmetri-
cally oriented in a helix fashion, and there is some spread to the distribution of fiber angles.
These fibers have dynamic roles in the makeup of artery walls, and characterizing that role
is ongoing research in arterial wall modeling.
According to [Kroon 2007], fibers are largely circumferentially oriented near the
interior surface (5–10◦ from circumferential); helically oriented near the exterior surface
(50◦ from circumferential); and vary smoothly between.
Histology studies suggest arteries begin healthy, deform into a bleb without a neck,
then into a saccular shape with a clear neck. (The neck does not seem to form by a “pinch-
ing” of a fusiform aneurysm.) This understanding is based on shapes of aneurysms com-
monly observed; there is comparatively little longitudinal data. Growing aneurysms are
considered deadly and would be intervened upon if possible. Histology studies suggest a
localized region of healthy tissue becomes overly weakened, such that it cannot maintain
its healthy shape, and bulges outward due to blood pressure. Weakening occurs due to loss
of the muscular layer and also disruption of the collagen fiber network. Structural changes
occur within the artery wall, causing the tissue increases its surface area (by production of
new tissue, not necessarily by stretching like a balloon).
Some researchers and clinicians suggest that some people may be born with a
propensity for localized degradation of arterial tissue. Congenital aneurysm disease I clas-
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sify as arterial malformation; it is not in the scope of this work. In this work, I investigate
only acquired aneurysm disease.
Animal testing has yielded limited results. Methods for causing aneurysms—such
as suturing in a pocket of tissue, degrading the aneurysm wall with chemicals, and phys-
ically scarring the arterial wall—cause unnatural structural changes. It is unclear what
value they have for predicting progression of naturally-formed human aneurysms. New
techniques for evaluating aneurysms are imperative.
Aneurysms have several mechanical measures by which their risk of rupture is
evaluated. The main ones are maximum diameter, rate of expansion, and wall shear stress.
Saccular aneurysms also have the neck-to-height ratio. Maximum diameter is widely con-
sidered inadequate, the rate of expansion is almost never known, wall shear stress cannot
be measured,1,2 and neck-to-height ratio is unreliable [Nader-Sepahi 2004]. Aneurysms
regularly defy the measures: many small aneurysms rupture, and many large aneurysms
do not. Owing to studies showing enlargement is correlated with rupture, maximum di-
ameter is the predominant clinical standard. Upper and lower boundaries for dictating
treatment are deliberately vague and based on a balance of risks.3
As treatment becomes safer and more effective, treatment guidelines have become
more aggressive. Overtreatment is an imperfect solution, however. We need predictive
models to become more selective and more accurate with our treatment choices.
1 Also, while abnormal wall shear stress is used to indicate danger, it is not settled whether or in what con-
ditions high or low wall shear stress is protective or harmful, nor even a range of “safe” levels of wall shear
stress.
2 Wall shear stress can be reverse engineered in some situations [Lu 2013].
3 A physician must also consider associated symptoms, suitability for surgery, and patient and familial his-
tory.
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2mm0mm
avoid surgery physician’s discretion
7mm
prefer intervention
maximum diameter of aneurysm
Figure 6: Cut points showing what appear to be current-practice guidelines for cranial aneurysms
[Beck 2006, commentary]. Large and small aneurysms have accepted treatments; a new tool’s great-
est utility lies in regions of uncertainty.
For each type of aneurysm, if the maximum diameter is below a lower bound (as-
suming the aneurysm is otherwise uncomplicated), surgery is usually not performed. See
Figure 6. Above some upper bound, physicians will tend to strongly recommend inter-
vention. In between, physicians have discretion—this is where a predictive tool finds its
greatest effect. Focusing on this limited range of the commonest aneurysms maximizes the
applicability of one’s efforts and has the greatest value to the medical community.
Before operating on an intracranial aneurysm, a physician insists upon seeing an
image of the aneurysm in order to envision its geometry in three dimensions. The physi-
cian is not satisfied with seeing one or two orthogonal projections—s/he wants to rotate a
three-dimensional surface representation or to increment through parallel slices.
This insistence upon a three dimensional representation demonstrates a belief that
the geometry of an aneurysm is a key feature of its treatment. In fact, aneurysms with irreg-
ular walls or blebs are known to be more dangerous than less complicated ones. Physicians
need tools that evaluate geometry in terms of its risk of worsening. Geometric quantifiers
must be developed.
This work is a necessary step toward the greater goal of establishing a geometric
quantifier for the evaluation of an aneurysm’s disease progression. The quantifier should
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provide a risk measure for physicians to understand the likelihood of the aneurysm’s en-
largement. It should also provide a means of comparing risk of one shape in one environ-
ment with the risk of a different shape in a different environment, but to do that, one must
first build predictive modeling and simulation tools.
The medical community is ready for these tools. A patient-specific computational
tool for the evaluation of aneurysms can be easily inserted into the differential diagnosis
physicians and hospitals use to treat this condition:
1. It will use imaging data already taken for this condition.
2. Its use will not contradict or invalidate any existing treatment options.
3. Physicians already want this capability.
4. No tool exits to perform the task.
Now is the time to build one.
The current work develops understanding of the mechanics of growth and remod-
eling of solids with two fiber families through rate-dependent inelastic strain. As shown
below, this is my geometric quantifier.
A main focus of the current research is to provide a medical professional with
a detailed geometry that accurately depicts the nuances of a patient-specific aneurysm.
Accurate geometries will enable precise predictions of the aneurysm’s behavior. Current
technology allows only general predictions.
Modeling pipelines are necessary since most medical imaging is designed for visu-
alization and is not suitable for computation. (Some threshold-based computational tech-
niques exist for raw CT data.) Several pipelines have been developed for this work. A
preliminary pipeline, used to model the human heart, is discussed below. See Figure 7.
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One of the characteristic features of an imaging pipeline is its segmentation pro-
cess. Segmentation is intractable, and a segmentation process which yields good results for
one organ and imaging modality often does not work well for a different organ or modality,
even if the two organs share a boundary. For instance, in segmenting the lungs, one may
be tolerant of including pulmonary vessels here and there; in segmenting the pulmonary
vessels, incorrect connections can completely change the structure of the pulmonary net-
work.
The current work brings together several emerging lines of research on vascular
anatomy and hemodynamic simulation. Among the territories which have been over-
looked is the development of physiologic boundary conditions for the arterial wall.
1.4 Constitutive modeling background
Aneurysms are common, life threatening, and poorly understood. It is nearly im-
possible to observe the disease process which leads to aneurysms, especially in early stages.
As a result, little is known about causes of the disease, and there is no strongly-correlated
marker of patient prognosis. Several things are known. Biomechanical extension tests
of artery tissue show an elastic response to applied loads at low-to-moderate strain; ir-
reversible damage to the arterial wall is the main proponent of aneurysm rupture; and
collagen fiber remodeling is a chief mechanism of damage. These observations suggest
nonlinear solid mechanics is an appropriate framework for investigating onset and pro-
gression of aneurysms.
Significant research has been performed on careful analysis of elastic properties of
aneurysms (strain energy coefficients, fiber directions, fiber dispersion). In addition, some
recent work has been performed on insensitivity of aneurysm models to elastic parameters.
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In this work, I gather results and observations from that body of research into an elastic
model. On top of that, I investigate properties of an inelastic theory. The inelastic theory is
an improvement over existing constitutive models in that it has the capability to produce
realistic saccular aneurysm geometries, which no other theory has been shown to produce
from a healthy artery.
1.4.1 Homeostatic stress
One common theory assumes that tissues enjoy a so-called “homeostatic” normal
stress level [Humphrey 2000], and that they actively remodel in order to restore their ho-
meostatic stress to this level. Improved understanding over the last several decades has
led to the recognition of several mechanisms for creating and preserving this homeostatic
stress in the face of hypertension, remodeling, aging, residual stresses, etc.
It has been concluded that collagen types I and III are deposited oriented accord-
ing to stresses and/or strains experienced by the wall at the time of deposition, and they
are deposited with a pre-existing internal stretch. Proper expressions for the orientation
of collagen fibers and their so-called “pre-stretch” is a subject of ongoing study. Studies
suggest the extracellular matrix structure regulates arterial strain in the long term, and
smooth muscle tone acutely modifies residual strain [Zeller 1998]. A satisfactory model
quantifying these behaviors remains elusive.
Material properties for constitutive equations and kinetic parameters for evolu-
tion equations describing fiber remodeling were measured for mouse arteries ex vivo in
[Gleason 2007], extending work that was presented in [Humphrey(2) 2002].
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1.4.2 Fiber reorientation
A somewhat recent advance in continuum modeling of arteries is the incorporation
of various effects of collagen fibers in the artery wall. Current research has been directed
toward understanding how the tissue updates its fiber properties (fiber direction, strength,
or numbers of cells) based on mechanical stimuli. These kinds of developmental changes
occur at a timescale of months, much longer than the one-second timescale of the cardiac
cycle. Since the actual timescales of the changes being modeled is unknown, it is common
to consider theories of fiber reorientation without specification of a timescale, and to con-
nect only beginning and/or end point configurations with clinical observations. (When a
timescale is used, it is typically the lifetime of collagen fibers, about 70 days.)
These phenomena be modeled as aging, healing, pathogenesis, or simple main-
tenance; and it can measure changes to arteries under hypertension, disease, surgery, or
medical management.
1.4.3 Transversely isotropic fibers
Recent research suggests fibers in arteries can be modeled as having “preferred”
directions. The preferred direction may change with time or stress. The overall tissue
response can be modeled as isotropic, consisting of multiple fiber families. There appear to
be multiple preferred directions in arteries. The angle of these directions changes through
the thickness, with deeper fibers being more circumferentially oriented, and superficial
layers having fibers that are more axially oriented. (See Figure ??.) In [Holzapfel 2000],
the author presents the “Gasser model,” a theoretical formulation of two families of fibers
perfectly aligned in directions at a specified angle γ from the circumferential. The model
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assumes an incompressible hyperelastic arterial wall with a strain energy function defined
by
Ψ(C) =
µ
2
( I¯1 − 3) + ∑
i=4,6
k1
2k2
[
exp
(
k2( I¯i − 1)2
)
− 1
]
,
with material constants k1 and k2 and invariants
I¯1 = tr C¯ ,
I¯4 = aˆ0 · C¯aˆ0 , and
I¯6 = bˆ0 · C¯bˆ0 . (1)
The symbol C¯ = J−2/3FTF represents the isochoric part of the deformation tensor, and
aˆ0 and bˆ0 are the directions of the fiber families in the reference configuration. The fibers
are assumed to act only under tension, so the I¯4 and I¯6 terms are ignored if they are less
than 1. With this formulation, the authors formulate a complete theory of fiber-reinforced
hyperelastic solids. In [Kroon 2007], the authors use this formulation in a structure-based
saccular aneurysm model allowing fiber reorientation.
1.4.4 Collagen turnover models
Humphrey and Taber propose, in [Humphrey 2000], that growth4 in arteries is
based on arteries remodeling their geometry to restore to normal levels, both the circumfer-
ential wall stress and wall shear stress due to blood flow. It is thought that the remodeling
itself can create, as a byproduct, enlargement of a weakened artery wall into an aneurysm.
4 The authors define growth as the addition of mass, independent of accompanying deformation. This is to be
distinguished from enlargement, which describes an increase in the volume of blood the aneurysm can surround.
In the current work, I use the same definitions.
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The artery wall is modeled in [Baek 2006] as a membrane by terms Wk in the strain
energy function—terms which provide for collagen production and removal.
w(t) = ∑
k=1,2
(
initial + historical
)
= ∑
k=1,2
( Mk(0)
ρ
Qk(t)Wk(0, t) +
tˆ
0
mk(τ)
ρ
qk(t− τ)Wk(τ, t) dτ
)
“Initial stress” refers to any stresses present at time 0, when computation begins.
The initial mass fraction of the k-th constituent is Mk(0)/ρ.5 The decay term Qk(t− 0) mit-
igates the initial stress of the k-th constituent to simulate the gradual turnover (particularly,
the removal) of collagen present at time 0. The stress Wk(0, t) is the stress at the current
time t of the collagen present at the initial time 0.
“Historical stress” refers to the stress developed during aneurysm growth, from
time 0 to the current time t. It uses the same format as the initial stress term—it has a
volume term mk(τ)/ρ, a decay term qk(t− τ), and a stress term Wk(τ, t). The stress term
Wk(τ, t) is the stress at the current time t of the collagen deposited at time τ.
Postulating an initial weak section of an otherwise healthy straight cylindrical
artery, the authors observe the changes in geometry and thickness (volume per unit area)
due to turnover of fibrous constituents. “Old” fibers, which may be under high stress (or
low stress), are removed by the body and replaced with “new” fibers, under their initial
pre-stress. The material thus becomes inelastic. See [Humphrey 2000]. The amounts of
“new” versus “old” fibers may differ. Humphrey, et al. believe these changes are realistic,
measurable in vivo, and contribute an attributable risk of aneurysm enlargement.
5 The artery wall is modeled as a membrane; volume and thickness are computed during postprocessing.
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It is believed that arteries remodel according to the stress they feel on the cardiac
timescale, and also the time rates of stress. That is, if Scardiac is some sort of stress average
felt by the artery and SFSI is a stress due to short-term blood dynamics, then Scardiac may
depend on SFSI, S˙FSI, S¨FSI, etc. A proper rule for this dependence is not known.
1.5 Highlights
1. A new growth and remodeling formulation in a 3D solid mechanics model using
isogeometric analysis is developed.
2. It utilizes subject-specific geometries from clinical image data and for application to
disease progression in vivo.
3. It implements realistic fiber microstructure.
4. It proposes a Winkler foundation term to describe the effect of basal tone and tether-
ing of arteries to external organs.
5. It proposes a rate-dependent inelastic model of aneurysm growth.
6. It identifies parallels between mathematical properties of the model and clinical di-
agnoses.
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Chapter 2
Solid mechanics
Ω0 Ωt
ϕt
X x
Figure 8: ϕt : Ω0 → Ωt.
I use continuum mechanics to describe the motion of artery
walls in humans. I assume artery walls are a continuous
medium whose motion is dictated by the forces applied
and internal stresses.
Biological tissues in vivo change mass. While most
mass increase occurs during adolescence, change of mass
in adults is an important indicator of health. This is a long timescale process on the order
of weeks to years, a similar timescale to the progression of aneurysm disease.
I do not explicitly model the influx of nutrients or reuptake of cells. My simula-
tions of enlargement of aneurysms allow volume changes at constant density—mass is not
conserved. When mass increases, I say there is “growth”; and when it decreases, “decay.”
The term “enlargement” will refer to deformation which increases the apparent size of the
simulated aneurysm. Enlargement is independent of growth.
I use growth kinematics to derive my constitutive equations. It turns out they are
largely unchanged from kinematic setups without growth. Conservation of mass has a
simple change, and the conservation of linear and angular momentum are unchanged. I
do not consider thermodynamics or entropy.
The mechanics of a growing mass are well known. For example, [Lubarda 2002]
presents a thorough treatment, beginning with the balance laws. I choose not to dupli-
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cate that effort. Here I present a brief treatment in the vein of [Lubarda 2002], to establish
notation and state my governing equations.
2.1 Notation
Suppose there is a body B of a continuous material that occupies the region Ω0 ⊆
R3 at time t = 0, and that ϕt : Ω0 → Ωt is a motion of the body to a (possibly different)
region Ωt ⊆ R3 at time t, for t ∈ [0, T]. See Figure 8.
As usual, write x = ϕt(X) = ϕ(X, t). Assumeϕ0 : Ω0 → Ω0 is the identity map.
Write the velocity v as v(x, t) =
( d
dt |X
)
ϕ, where ddt =
d
dt |X is the material time derivative.
The deformation tensor F is F = ∇Xϕ(X, t) = ∂x∂X . The determinant J = det F. The
right Cauchy–Green deformation tensor is C = FTF. The Second Piola–Kirchhoff stress is
S. Cauchy stress is σ. The Green–Lagrange strain tensor E = 12
(
FTF− I). The strain tensor
e = 12
(
FFT − I).
2.2 Balance laws for a growing mass
Suppose that for each material point X, the material’s mass grows at some rate
R ∈ R. The value of R may change over time: R = R(X, t). If R > 0 there is growth,
and if R < 0 there is decay. Though the material grows, it is assumed to be a continuous
material in space. Therefore, every spatial point in the body at time t is assumed to have
existed at time 0. All calculations, then, can be expressed appropriately in material or
spatial coordinates. In spatial coordinates, I would use a lowercase letter: r = r(x, t) ∈ R.
In the case of conservation of mass, r ≡ 0.
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2.2.1 Continuity equation
Write dm for a differential unit of mass, and dv and dV as a differential volume
elements for the current and material volume, respectively. Define r such that
d
dt
dm = r dv ,
and ρ = dm/dv as the current mass density. Then
r dv =
d
dt
(dm)
=
d
dt
(ρ dv)
=
( d
dt
ρ
)
dv+ ρ
d
dt
dv . (2)
Volume growth is proportional to the divergence of the velocity field:
d
dt
dv = (∇x · v) dv . (3)
Combining (2) and (3) into
dρ
dt
dv+ ρ (∇x · v) dv = r dv ,
I achieve the continuity equation for a growing mass:
dρ
dt
+ ρ (∇x · v) = r . (4)
The current volume density ρ is assumed to be nearly constant for all time, for all
points, so dρdt ≈ 0. My numerical formulation assumes a nearly incompressible material,
with a very high Poisson’s ratio. This is used as a simplifying assumption. Healthy artery
walls appear to keep a constant density during changes in fibrous structure. In aneurysm
development, artery walls appear to first reduce their density (loss of media layer), then
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increase it (increased collagen production), even as they become thin (due to degradation)
or thick (due to inflammation). Exploration of density of diseased tissue is not a feature of
this work.
Because dv = J dV, if I take R such that r dv = R dV, I have rJ = R.
2.2.2 Reynolds Transport Theorem
Consider a quantity q in the current configuration. The Reynolds Transport Theo-
rem is
d
dt
ˆ
Ωt
ρq dv =
ˆ
Ωt
(
ρ
dq
dt
+ rq
)
dv . (5)
2.2.3 Balance of linear momentum
Growth does not affect linear momentum.
For a body force b, surface normal n, and Cauchy stress σ, Euler’s first law of
motion for a growing mass is
d
dt
ˆ
Ωt
ρv dv =
ˆ
∂Ωt
σ · n da +
ˆ
Ωt
ρb dv +
ˆ
Ωt
rv dv . (6)
But by the Reynolds Transport Theorem with the velocity as q,
d
dt
ˆ
Ωt
ρv dv =
ˆ
Ωt
(
ρ
dv
dt
+ rv
)
dv . (7)
The integrands of (6) and (7) which contain the growth term cancel, giving the usual linear
momentum equations for a material without growth:
ˆ
Ωt
ρ
dv
dt
dv =
ˆ
∂Ωt
σ · n da +
ˆ
Ωt
ρb dv
ρ
dv
dt
= ∇x · σ + ρb . (8)
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Writing F = ∇Xϕt = ∂x∂X , ρ0 = ρJ, and R = rJ, Euler’s first law in material
coordinates reads
d
dt
ˆ
Ω0
ρ0v dV =
ˆ
∂Ω0
FSN dA+
ˆ
Ω0
ρ0B dV +
ˆ
Ω0
Rv dV
=
ˆ
Ω0
∇X · (FS) + ρ0B+ Rv dV .
Pulling the derivative inside the integral, and then using the fact ddtρ0 =
d
dt (ρJ) = R, the
left-hand side is
d
dt
ˆ
Ω0
ρ0v dV =
ˆ
Ω0
(
ρ0
dv
dt
+
d
dt
(ρ0)v
)
dV
=
ˆ
Ω0
(
ρ0
dv
dt
+ Rv
)
dV .
Together, they combine to give the balance of linear momentum in material coordinates.
ˆ
Ω0
ρ0
dv
dt
dV =
ˆ
Ω0
∇X · (FS) dV +
ˆ
Ω0
ρ0B dV +
ˆ
Ω0
Rv dV ,
or
ρ0
dv
dt
= ∇X · (FS) + ρ0B . (9)
2.2.4 Balance of angular momentum
Growth does not affect angular momentum.
In integral form, Euler’s second law of motion for a growing mass reads,
ˆ
Ωt
d
dt
(x× ρv) dv =
ˆ
Ωt
ρ (x× b) + r (x× v) dv +
ˆ
∂Ωt
(x× σ) · n da . (10)
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Master balance law:
d
dt
α =
∂
∂t
α+∇x · (αv) = β+∇x · γ .
d
dt
ˆ
Ωt
α dv =
ˆ
Ωt
β dv+
ˆ
∂Ωt
γ n da .
α β γ
quantity source flux
continuity (4) ρ r 0
momentum (spatial) (6) ρv ρb+ rv σ
angular momentum (10) x× ρv ρ (x× b) + r (x× v) x× σ
Table 9: Master balance law. This is the usual form, when conservation of mass holds (r ≡ 0). In
this form, it appears momentum depends on growth r, but the Reynolds Transport Theorem shows
momentum does not depend on growth.
Again by the Reynolds Transport Theorem, with (x× v) as q, the above becomes the usual
momentum equation
ˆ
Ωt
ρ
d
dt
(x× v) dv =
ˆ
Ωt
ρ (x× b) dv +
ˆ
∂Ωt
(x× σ) · n da . (11)
Therefore I still achieve symmetry σ = σT of the Cauchy stress.
2.2.5 Master balance law
The above equations can be summarized in a master balance law. It is interesting
to note how growth disrupts the cleanliness of this representation. Table 9 shows the usual
spatial form of the master balance law, and the integrands which create each balance law.
The usual form of the master balance law obscures the lack of dependence on growth for
momentum.
Alternatively, consider Table 10. In that table, I have incorporated mass density
into the master balance law (by simply applying the Reynolds Transport Theorem). After
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Transported master balance law:
ρ
d
dt
η = ρ ξ +∇x · γ .
ˆ
Ωt
ρ
d
dt
η dv =
ˆ
Ωt
ρ ξ dv+
ˆ
∂Ωt
γ n da .
η = α/ρ ξ = β− rη γ
quantity source flux
(continuity) 1 0 0
momentum (spatial) (8) v b σ
angular momentum (11) x× v (x× b) x× σ
Table 10: Alternative form for a master balance law. Linear and angular momentum are revealed to
be independent of growth. Interestingly, in this form the continuity equation reads 0 = 0+ 0.
having done so, the master balance law reveals the lack of dependence on r. The continuity
equation in this form becomes trivial.
2.3 Boundary-value problem statements
Here I state the initial–boundary-value problem in general terms. To state the an-
eurysm problem, I begin with linear momentum. I assume a quasi-static material, and end
with the usual large deformation kinematics setup for a solid subject to Dirichlet, Neu-
mann, and body force conditions. The strong and weak formulations are stated here. The
Galerkin form is given in § 4.1 below. Additional specifics for each simulation will be given
together with the simulation results, in Chapters 6.
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2.3.1 Quasi-static assumption
The timescale of growth and remodeling is long, much longer than the action of in-
tertial or transient effects. At each timestep, I assume the material has reached equilibrium,
and therefore has no velocity. I do not model acute injury, or motion or acceleration of the
person’s head. Despite the material’s velocity being zero, it undergoes motion, because its
material properties evolve from timestep to timestep. The solid is said to be “quasi-static”1.
That is,
v = ϕ˙≡ 0 .
Therefore, linear momentum (8) and (9) become the familiar
∇x · σ + ρb = 0 ,
∇X · (FS) + ρ0B = 0 . (12)
The Cauchy stress is σ, the Second Piola–Kirchhoff stress is S, mass density in material
coordinates is ρ0 = ρJ, and body forces are b = b(x, t) and B = B(X, t) = b(x, t) ◦ ϕ(X, t).
Gravitational forces will be neglected, but later on (in §3.9) I will introduce a Winkler body
force.
2.3.2 Strong form
The traction conditions are as in Figure 11. The interior surface of the in vivo artery
is assumed to feel the equivalent effect of a constant, average blood pressure pBP, and the
outer surface is assumed to feel the pressure pbrain of the cerebral spinal fluid. Both these
pressures are maintained in the spatial description. (They are follower forces.)
1 This is a common assumption for long-term effects. In my simulations, including dynamic effects improved
convergence.
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X
r(X, t)
mass growth
fixed in axial direction
pbrain
pBP
B
Figure 11: The body B in the growth problem.
The material is a continuous solid with a grow-
ing mass. Internal and external pressures are
shown. The simulation is quasi-static, growth
being on a timescale of weeks to decades.
Γinlet
Γoutlet
B
Γinterior
Γexterior
Figure 12: Definitions of the boundary subsets
of the artery.
Specifically, define sets comprising the boundary ∂B = ∂Ω0 as in Figures 11 and 12:
Γg = Γg0 = Γinlet ∪ Γoutlet
Γh = Γh0 = Γinterior ∪ Γexterior
Γgt = ϕt(Γg0)
Γht = ϕt(Γh0) , (13)
and define essential and natural boundary conditions
g(X, t) ≡ const in axial direction, on Γg
h(X, t) ≡ pBP, on Γinterior
h(X, t) ≡ pbrain, on Γexterior . (14)
Then for each t in [0, T], the strong form of the boundary value problem is
(GNR, S)

Given g, h as above, findϕ ∈ H1(Ω0) such that
∇x · σ + ρb = 0 in Ωt
ϕ≡ g on Γgt
σn = hn on Γht .
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It is important to observe that because the natural configurations evolve with t,
the material properties embedded in σ are time-dependent, and so the boundary value
problems also have a time dependence.
2.3.3 Weak form
Define the “space” of candidate solutions and the space of test functions to be
S = {ϕ ∈ H1(Ω0) : ϕ Γg ≡ g} and (15)
V = {ψ ∈ H1(Ω0) : ψ Γg ≡ 0} . (16)
Multiplying the constitutive equation (12),
0 = ∇X · (FS) + ρ0B ,
by a test function ψ and integrating by parts gives
0 =
ˆ
Ω0
ψ · (∇X · (FS) + ρ0B) dV
= −
ˆ
Ω0
(∇Xψ) : (FS) dV +
ˆ
∂Ω0
ψ · (FS)N dA +
ˆ
Ω0
ψ · ρ0B dV
= −
ˆ
Ω0
(∇Xψ) : (FS) dV +
ˆ
Γh
ψ · JhF−TN dA +
ˆ
Ω0
ψ · ρ0B dV . (17)
The outward-pointing unit normal in the reference configuration is N, and J = det F. The
area element dA is related to da via the familiar relation n da = JF−TN dA.
In index notation2—where repeated indices are summed over values 1, 2, 3—
equation (17) becomes
0 = −
ˆ
Ω0
ψi,J F iISI J dV +
ˆ
Γh
ψi JhF
−T
iI N I dA +
ˆ
Ω0
ψi ρ0Bi dV. (18)
The comma index notation indicates a derivative: ψi,J = ∂ψi/∂X J .
2 The symbol J as a subscript is an index.
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The weak formulation then becomes the task
(GNR, W)
 Given g, h, as above, findϕ ∈ S such that for all ψ ∈ V ,(ψi,J , F iISI J)Ω0 =
(
ψi, JhF
−T
iI N I
)
Γh
+
(
ψi, ρ0Bi
)
Ω0
.
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Chapter 3
Constitutive model
In this chapter, I shall discuss the manner in which I define stress.
I begin with a hyperelastic model which roughly describes the behavior of soft
tissue under normal, healthy loading conditions. On top of that, I add inelastic properties
which describe the behavior of the collagen fibers inside of artery walls under diseased,
unhealthy conditions.
To describe aneurysm disease, I developed a rate-dependent inelastic continuum
model for artery tissue. It has several guiding principles.
One guiding principle of this work is collagen turnover cannot by itself explain
cranial aneurysms: aneurysm development can happen at timescales much faster (days–
weeks) and also much slower (years) than the timescale of the body’s replacement of col-
lagen fibers (months). Instead of the theory of turnover, usually modeled as “fading mem-
ory,” a theory of inelasticity is implemented. Other guiding principles are the following.
• Collagen fibers are the predominant load-bearing constituent of arteries.
• While arteries have multiple distinct layers, modeling them as a single-layered ho-
mogeneous material is sufficiently accurate.
• Non-collagen-fiber material can be modeled as a soft elastic material.
• Disease states can be modeled as irreversible processes instead of a return to homeo-
stasis.
• Existing biomechanical theories for saccular aneurysms have limitations.
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3.1 Fiber direction
Collagen fibers arrange themselves in layers, with each layer having symmetrically-
arranged fibers pointing in preferred directions. Fiber direction has been studied exen-
sively in the literature, but there has been little connection shown between fiber direction
profiles and aneurysm behavior. My own studies of fiber direction are consistent with this,
and the model I present is not very sensitive to fiber direction. For that reason, I use a
simple fiber direction model. I elaborate on the profile I choose (±45º from axial) in §5.9.
The fiber direction profile is prescribed as a vector field M = M(X).
∥∥M∥∥ = 1
everywhere. Also, λ is the stretch ratio in the fiber direction:
F = ∇ϕ
m = FM
λ = ‖m‖ .
3.2 Elastic strain
The material model used is presented as a strain energy function. The existence
of a strain energy function w = w(t) = w(X, t) comes from the hyperelastic assumption
[Gonzalez 2008]. Here the notation is
S =
∂w
∂E
= 2
∂w
∂C
.
The strain energy function comes in two major parts. One is the background ma-
terial’s energy, and the other is the fiber energy. The first part’s purpose is to represent the
stiffness of the “background material” of the artery.
There is considerable debate in the literature over which strain energy functions
are the most appropriate to use. For this work, the background material is the neo-Hookean
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formula of equation (20) from Ciarlet [Simo, Hughes 1998], and collagen is the exponentially-
stiffening material of (21), postulated in [Baek 2006]. Straightforward strain energy func-
tions are used here; the purpose of this work is to investigate inelastic properties, not elastic
properties.
I separate the constitutive model for arteries into two parts: that of a soft hyperelas-
tic volumetric background material Wvol from [Ciarlet 1988], and exponentially-stiffening
one-dimensional collagen fibers Wfib from [Baek 2006].
As is common modeling assumption, I suppose there are two families, numbered
k = 1 and k = 2. A fiber from family k will be referred to as a k-fiber. The fiber strain
energy Wk is a function of one variable, the square of the elastic stretch ratio in the fiber
direction. Write Mk for the fiber direction in material coordinates, and mk(t) = F(t)Mk for
its push-forward into current coordinates.
The overall stretch ratio of a fiber is denoted like this:
λ2 = m ·m = (FM) · (FM) = M · FTFM = M · CM .
The stretch ratio is decomposed into an elastic amount and an irreversible (inelastic) amount:
λk = λkel λ
k
irr .
The elastic amount can be determined by dividing:
λkel = λ
k/λkirr .
The meaning of irreversible strain will be discussed shortly (in sections 3.6, 3.7,
and 3.8). Here, I describe the material’s elastic properties.
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A lowercase w is used for the overall strain energy, to avoid confusion with com-
ponent energy terms W.
w =Wvol + ∑
k=1,2
Wk (19)
Wvol =Wvol(J) = λLamé
(1
4
(
J2 − 1)− 1
2
(
ln J
))
+ µLamé(tr E− ln J) (20)
Wk =Wfib
(
(λkel)
2) = c1(exp [c2((λkel)2 − 1)2]− 1) . (21)
For simplicity, the k indicating fiber direction will often be dropped. Constants
c1 and c2 are material parameters. Their values are given together with the results. The
Green–Lagrange strain tensor E is 12
(
FTF − I).
Because fiber strain energy depends only on the stretch ratio in the fiber direction—
there are no cross-sectional or shear effects—its stress tensor is uniaxial:
Sfib = 2
∂Wfib
∂C
= 2
dWfib(λ2el)
d(λ2el)
∂λ2el
∂λ2
∂λ2
∂C
=
[
2W ′fib(λ
2
el)
1
λ2irr
] ∂λ2
∂C
=
[
2W ′fib(λ
2
el)︸ ︷︷ ︸
sel
1
λ2irr
]
(M ⊗M) =
[ sel
λ2irr
]
(M ⊗M) . (22)
This is thanks to the convenient well-known observation
∂
∂C
λ2 =
∂
∂C
(
M · CM) = (M ⊗M) .
Setting sel = 2W ′fib(λ
2
el) is a notational convenience designed to reiterate that sel
depends only on elastic quantities.
3.3 Isotropic, hyperelastic background material
The background material is a soft volumetric material whose purpose is to main-
tain the artery’s thickness during inflation. It repesents the non-collagen portions of the
artery.
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Figure 13: Physical inter-
pretation of fiber Cauchy
stress. Fibers should
be thought of as in-
dividual proteins con-
necting two infinitesimal
parallel plates. Fiber
Cauchy stress does not
change with changes to
the cross-sectional area
of the plates, or to ir-
reversible strain in the
fibers.
This choice could be replaced with a two-dimensional
membrane material. That would alleviate several struggles with
the simulation that have nothing to do with the constitutive model
I present. Namely, using a thick-walled material creates opportu-
nities to deal with bending stiffness, locking problems, and New-
ton convergence issues where a deformation with det F < 0 is
attempted. I chose to use a thick-walled material to pave the way
for future research in modeling inflammation, atherslcerosis, and
other thickness-related processes in arteries.
3.4 One dimensional, independently-acting colla-
gen fibers
As I have seen, in this theory, fiber strain energy and
stresses are uniaxial quantities. This definition of Cauchy stress
for collagen has a good physical interpretation: that of individual
fibers connecting two infinitesimal plates. (See Figure 13.) First, stress depends on elastic
strain. Second, irreversible strain λirr of fibers has no effect on stress. Third, strain normal
to the fibers has no effect on stress. That is, expansion and contraction of the infinitesimal
plates only changes the (infinitesimal) distance between the cables, not their stress.1
1 This is a modeling assumption. In tissues, as with textiles, perpendicular strains are not entirely decoupled:
large strain in one direction leads to a greater stress–strain response in normal directions.
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3.5 Derivatives of the strain energy
Here are the expressions for the Second Piola–Kirchhoff tensor S and the elasticity
tensor C for the growth and remodeling timescale as the first and second derivatives of the
strain energy function W with respect to C.
Continuing the work done in equation 22, the contributions from the fibers
(
see
equation (21)
)
have derivatives
W ′fib(λ
2
el) =
dW
dλ2el
=
d
dλ2el
c1
(
exp
[
c2
(
λ2el − 1
)2]− 1)
= c1 exp
[
c2
(
λ2el − 1
)2] · 2c2(λ2el − 1) (23)
SkI J = 2
∂Wk
∂C I J
=
[
2W ′fib(λ
2
el)
1
λ2irr
]
M IM J
= 2c1ec2(λ
2
el−1)2 2c2(λ2el − 1) M IM J (24)
CkI JKL = 2
∂SkI J
∂CKL
= 4c1ec2(λ
2
el−1)2 2c2(λ2el − 1) M IM J 2c2(λ2el − 1) MKML
+ 4c1ec2(λ
2
el−1)2 2c2M IM JMKML .
= 4c1
(
4c22 (λ
2
el − 1)2 + 2c2
)
ec2(λ
2
el−1)2 M IM JMKML . (25)
3.6 Aneurysm enlargement as irreversible strain
I choose to model the enlargement of aneurysms using a rate-sensitive inelastic
theory. The main reason for doing so is that I do not believe, as some researchers do
[Baek 2006, Kroon 2007], that disease is well-modeled as a (perhaps flawed) return to ho-
meostasis. More generally, I believe the predominant theories in the literature cannot ac-
count for the etiology of saccular aneurysms. A new approach is needed.
I view disease as irreversible alterations in both structure and function of arterial
tissue. Arterial tissue behaves elastically within physiologic regimes, and if the tissue is
strained above some limit, it undergoes irreversible strain.
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3.7 Definition of irreversible strain
A preliminary model I devised uses irreversible strain defined by the following
equations.
collagen Cauchy stress tensor: σfib = σ (mˆ⊗ mˆ), mˆ = m/‖m‖
collagen Cauchy stress scalar: σ = mˆ · σfibmˆ
elastic strain: λel =
λ
λirr
, λ = ‖m‖
flow rule: λ˙irr =
〈φ〉
τrelax
, φ =
σ
k
− 1 , 〈x〉 ≡
{
x x > 0
0 x 6 0 .
pseudoelastic limit: k = k
(
σ, x, t; ϕ(x, [0, t])
)
hardening law: k˙ = k˙irr + k˙les
irreversible hardening: k˙irr = λ˙irrHirr
lesion onset (softening): k˙les = k˙les(x, t)
= Hles(kles − k∞les) , k∞les = k∞les(x, t) .
A few remarks about these modeling choices:
1. I use the notation of a boldface σ for the Cauchy stress tensor; and a lightface σ for
a scalar representing Cauchy stress. I often use the scalar when discussing collagen
Cauchy stress, especially in Chapters 6–7. This is not such an abuse of notation be-
cause collagen fibers are one-dimensional (in my model) and their stress tensor is
uniaxial. (See the following remark.)
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2. Fibers, as one-dimensional quantities, have no volume. The Cauchy stress, like the
2nd Piola–Kirchhoff stress, is uniaxial:
σfib = J−1FSfibFT
= J−1F
[ sel
λ2irr
]
(M ⊗M) FT = J−1
[ sel
λ2irr
]
F (M ⊗M) FT
= J−1
[ sel
λ2irr
]
(FM ⊗ FM) = J−1
[ sel
λ2irr
]
(m⊗m)
=
(
J−1
[ sel
λ2irr
]
λ2
)
(mˆ⊗ mˆ)
= σ (mˆ⊗ mˆ) ,
with the scalar σ =
(
J−1
[ sel
λ2irr
]
λ2
)
= J−1selλ
2
el .
3. The scalar σ is a function of space and time, as well as the full time history of defor-
mation. In this sense, the material is hyperelastic with memory.
4. The von Mises effective stress is
√
3
2 s(σ) : s(σ), where the stress deviator s(σ) is σ−
1
3 (trσ)I. If σ is a scalar a times (mˆ⊗ mˆ) for some unit vector mˆ (which is fortunately
the case for us), then the von Mises effective stress is simply |a|, which is also mˆ · σmˆ
for a > 0. In this case, the flow rule used in this work, 〈φ〉/τrelax = 〈 ak − 1〉/τrelax,
is the Perzyna model with rate sensitivity 1 and viscosity-related parameter τrelax
[de Souza Neto 2008, p. 448].
5. The timescale τrelax determines the response rate of fibers in my simulated arteries.
Its value affects the rate of enlargement of simulated aneurysms. I define it as an ap-
proximate timescale of fiber turnover, 70 days. Some researchers argue the turnover
rate is accelerated in disease. I choose not to use a variable turnover rate, for lack of
experimental data supporting material parameters of disease.
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6. The bracket 〈·〉 is the “positive part” of its argument:
〈x〉 ≡
{
x x > 0
0 x 6 0 .
(For numerical stability, I round off the corner. See the footnote on page 67.)
7. The pseudoelastic stress limit k = k(x, t) is a function of space and time, and also of
the current fiber stress σ, and the deformation historyϕ(X, ·) of the point X.
8. The pseudoelastic limit varies according to two terms, k˙irr and k˙les. The first is a
rate due to material hardening, and the second is a rate due to softening from lesion
progression. That is, in this model, the pseudoelastic limit is initially high (as with
healthy tissue) (σ > k), then decreases as the lesion grows (disease) (k˙les < 0). Even-
tually, the limit drops below healthy levels (σ < k) and irreversible strain begins.
When irreversible strain begins, hardening occurs (k˙irr > 0), which may stabilize the
artery (healing). The pseudoelastic limit then evolves according to the balance of
these two terms.
9. Lesion onset is postulated as a reduction in the pseudoelastic limit term k∞les. The
value of kles follows the (time- and space-varying) postulated value k∞les. I could alter
kles or k˙les (and thus k) directly; but for stability, k∞les alters kles indirectly, through the
control equation k˙les = Hles(kles − k∞les), whose steady-state solution is kles = k∞les.
10. I use two families of fibers, pointed perpendicular to each other, though this choice
is not fundamental. Many setups with an overall isotropic response can be used,
where the material can deform inelastically in the “tangent plane” perpendicular to
the thickness direction. In fact, the theory presented here is can be thought of as
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inelastic membrane strain, but I present it in terms of the “fiber family” formulation
currently in vogue. (A true membrane model would have a strain energy due to
shear.)
11. All fibers have the same material properties, except for the fiber direction, and are
governed by the same constitutive equations.
12. I take fibers to be pointed at ±45 degrees from the axial direction. The axial direc-
tion—indeed the entire circumferential–thickness–axial coordinate frame—is defined
by the push-forward of an ordinary thick cylinder onto the patient-specific geometry.
See Figure 28 on page 102. Fibers are taken to have zero dispersion [Wicker 2008].
13. The elastic background material is used for the volumetric component of strain en-
ergy. The Lamé parameter is set at a very incompressible .4995.
3.8 Adaptive irreversible strain
Like every other model in the literature, the methodology above produces sta-
ble aneurysms that do not quite go saccular. In order to produce saccular aneurysms, I
postulate that the pseudoelastic limit becomes dependent upon the current stress in the
aneurysm. By creating a feedback loop, the theory produced saccular aneurysms. This
is the first theory which has produced saccular aneurysm geometries from healthy artery
geometries.
My constitutive model involves an adaptive pseudoelastic stress, which depends
on the strain rate. Particularly, instead of specifying k˙les (done via k∞les) and observing
changes in λ˙irr, I specify changes in λ˙irr and observe changes in k˙les.
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elastic strain: λel =
λ
λirr
, λ = ‖m‖
collagen Cauchy stress tensor: σfib = σ (mˆ⊗ mˆ), mˆ = m/‖m‖
collagen Cauchy stress scalar: σ = mˆ · σfibmˆ
postulated strain rate: λ˙irr = λ˙irr(x, t)
flow rule: λ˙irr =
〈φ〉
τrelax
, φ =
σ
k
− 1
pseudoelastic limit: k = σ/(λ˙irrτrelax + 1)
irreversible hardening: k˙irr = λ˙irrHirr
lesion progression: k˙les = k˙irr − k˙
= λ˙irrHirr − ddt
[
a/(λ˙irrτrelax + 1)
]
= k˙les(σ, λ˙irr, x, t) .
This version of events is used when the irreversible strain rate is postulated to be positive,
so that the flow rule is activated. In this case the aneurysm is actively enlarging. Lesion
progression is determined by the postulated strain rate, instead of vice-versa (during pas-
sive enlargement). In fact, it would be better to say that lesion progression is defined by
the postulated strain rate. During time intervals where I have somewhat arbitrary choices
for settings of kles or λ˙irr (i.e., when σ < k), I choose so as to effect smooth functions of
time. See figures below in Chapter 6 for explicit time histories of chosen parameters and
resulting lesion progression.
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3.9 Winkler foundation and vascular tone
Diseased artery tissue is made up of different material when compared to healthy
tissue, and has a different biomechanical response. Both its structure and function are
different.
For example, healthy tissue has elastin and a smooth muscle layer. Diseased tissue
lacks these; it’s predominantly collagen. In developed aneurysms, aneurysmal tissue is
usually thinner—sometimes so thin as to be transparent, where a surgeon can see blood
flowing through the artery wall.
Therefore I model healthy and diseased tissue differently. I argue that due to irre-
versible cellular changes within the artery wall, diseased tissue cannot return to its healthy
state. This choice is different from the one in [Baek 2006] where turnover and evolving
natural configurations model disease as a flawed return to homeostasis.
In diagnosed aneurysms, there is a complete or near complete loss of the muscular
layer. Smooth muscle cells degenerate or modulate their phenotype in response to insult
or injury. Their behavior plays a central role in initiation of aneurysms as well as their
propensity for rupture [Starke 2014]. The degenerative process is not fully understood, but
involves both apoptosis (programmed cell death) and a reduction in the proliferation of
smooth muscle cells.
Once the contractile muscular layer is gone, aneurysms have a loss of basal vas-
cular “tone”—the degree of constriction of a vessel from its maximally dilated state. All
healthy vessels have tone. Tone is the active mechanism by which arteries maintain ho-
meostasis.
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As with every major process in the body, there are many competing influences on
tone. Tone is determined by a number of neurohormonal factors extrinsic to the vessel,
such as angiotensin II, atrial natriuretic peptide, and sympathetic nervous responses. It
also has influences intrinsic to the vessel, such as contraction initiated by myocytes within
the smooth muscle cells. If blood pressure increases, smooth muscle cells constrict to re-
duce flow; and if pressure lessens, vessels dilate to reduce vascular resistance and thus
increase flow. Further, “smooth muscle tone can acutely modify residual strain, possibly
through interconnections with matrix components” [Zeller 1998]; thus, ex vivo testing is an
imperfect method for determining in vivo residual stress. These factors and more combine
to effect the body’s strict regulation of blood flow rate to the brain.
These systemic and autoregulation processes are not present in aneurysms; aneu-
rysms always stay maximally dilated.
Figure 14: Winkler foundation. The material is
modeled as if tiny springs are attached at each
point, holding the material in its original posi-
tion. The “spring constant” is q, measured per unit
length (as depicted in this image) or volume (as
used in this work).
As a way of encapsulating these
observations mathematically, I introduce a
two-part lesion modulation. One part is
a reduction in Young’s modulus E inside
the lesion. Important to us is that reduc-
ing Young’s modulus lowers bending stiff-
ness while still maintaining incompress-
ibility. Another part is a so-called Winkler
foundation term.2 This term represents a macroscopic, combined model representing sev-
eral biological effects: loss of the muscular layer and thus loss of basal tone, loss of perivas-
2 Emil Winkler originally proposed the term as an elastic model for soil foundations underneath railway beds,
in [Winkler 1867].
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cular tethering by the extracellular matrix within and surrounding the artery, and loss of
support by adjacent tissues such as the brain and blood-brain barrier.
Aneurysmal tissue has no tone and no support, so its Winkler coefficient would be
zero. Healthy tissue has a high tone, active mechanisms to maintain its healthy state, and
so its Winkler coefficient would be high. This term is optional, and for thin structures I use
a Winkler term of 0.
A Winkler foundation is a penalty on displacement, as seen in Figure 14 and equa-
tion (26). It is as if each point in the tissue has a small spring attached to it, holding it in its
original position.
The Winkler term is often applied as a boundary term, acting on the surface of
(in this case) the artery wall. In this work, the Winkler term is approximated as a body
force, acting on the surface of the artery as well as in the interior. For thin structures this
approximation is acceptable.
The residual R is
R = Fext − (Fint − qd) = 0 , (26)
where q = q(X, t) is the volumetric Winkler stiffness coefficient. The Fext represents exter-
nal forces, Fint represents internal forces, d is displacement.
If I define the Winkler stiffness as a space-time function of, say, wall shear stress, I
could gain the power to allow the evolving geometry to dictate formation of an aneurysm
from a fluids calculation, and also better understand the aneurysm’s stability. For now, the
Winkler coefficient is arbitrarily chosen in advance.
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Figure 15: Stresses in an inflated aneurysm. Tension in artery walls from blood pressure or pre-
stress act to enlarge the neck of a saccular aneurysm. This effect occurs in simulations of realistic
3D aneurysms. Bending stiffness also acts to enlarge sharp necks in aneurysms. The Winkler force
opposes both of these.
3.10 Alternative growth theories
There have been several growth theories presented in the literature. I briefly present
a few of them in order to make mathematical comparisons of them.
3.10.1 Fiber turnover and evolving natural configurations
In this theory, from [Baek 2006], fibers fade over time and are replaced by newer
fibers. New fibers evolve their strain amounts and directions. Fix a material point X, an
arbitrary time τ ∈ [0, t] in the past, and take x = ϕτ(X). Suppose there is some natural con-
figuration Bk of k-fibers at time τ. Suppose, within Bk, that the direction Mk(τ) represents
the direction vector for a k-fiber created at time τ that is placed at x.
Define a vector Mk(τ) as the pull-back at time τ of ghmk(τ, τ) into a reference
configuration:
Mk(τ) = F−1(τ)ghm
k(τ, τ) .
Then the push-forward of Mkref(τ) into the current (time t) configuration is
F(t)F−1(τ)ghm
k(τ, τ) .
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Define mk(τ, t) as such:
ghm
k(τ, t) = F(t)F−1(τ)ghm
k(τ, τ) .
Then mk(τ, t) points in the current direction of the k-fiber. Note that mk(τ, t) with τ = t is
consistent with the notation mk(τ, τ) previously defined. Also, mk(τ, t) is in general not a
unit vector unless τ = t, and the stretch in the fiber is
λk(τ, t) :=
∥∥mk(τ, t)∥∥ .
Then λk(τ, t) is the stretch felt at the current time t by the k-fiber placed at x = ϕτ(X) at
time τ.
To illustrate this result, put the above equations together to derive a formula for
stretch separating the time variables t and τ:
λk(τ, t)2 =
∥∥mk(τ, t)∥∥2
=
∥∥F(t)F−1(τ)ghmk(τ, τ)∥∥2
=
∥∥F(t)Mk(τ)∥∥2
=
[
F(t)Mk(τ)
]T[F(t)Mk(τ)]
=
[
Mk(τ)
]TF(t)TF(t)[Mk(τ)]
= Mk(τ)TC(t)Mk(τ)
= Mk(τ) · C(t)Mk(τ) .
The deformation tensor C(t) = F(t)TF(t) corresponds toϕt of GNR.
The definition of fiber strain energy in [Baek 2006] is
Wk =Wk(τ, t) = c1
(
exp
 c2
(
g2h
Mk(τ) · C(t)Mk(τ)
Mk(τ) · C(τ)Mk(τ) − 1
)2 − 1) .
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Humphrey model: Wk =
tˆ
0
varies with t︷ ︸︸ ︷
q(τ − t)r(τ) c1(exp
[
c2
(
g2h
denominator constant with t︷ ︸︸ ︷(
λkcurrent
λkoriginal
)2
− 1
)2]− 1) dτ
New model: Wk =
︸ ︷︷ ︸
constant with t
c1(exp
[
c2
( (λkcurrent
λkirr
)2
︸ ︷︷ ︸
denominator varies with t
− 1
)2]− 1)
Figure 16: Comparison of the fiber turnover theory of [Baek 2006], commonly called the “Humphrey
model,” and the theory present here. In the new model, aneurysm enlargement proceeds at a pace
determined by λkirr. In the Humphrey model, aneurysm enlargement proceeds at a pace determined
by the changing time integral of q(τ − t)r(τ). Even though newer incarnations of this model use
changing profiles for q that depend on strain rates and other factors, function profiles for q and r
have not been found which create saccular aneurysms.
Now write
λkcurrent = λ
k(τ, t) = Mk(τ) · C(t)Mk(τ)
λkoriginal = λ
k(τ, τ) = Mk(τ) · C(τ)Mk(τ) ,
to compare this theory to the theory presented here.
The fiber turnover theory of [Baek 2006] uses a time integral for fibers:
tˆ
0
q(τ − t)r(τ)Wk(τ, t) dτ .
When I compare them side-by-side, as in Figure 16, I can see the differences between the
two theories.
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3.10.2 Mass production
Mass production is a crucial aspect of [Baek 2006] model’s behavior, and satisfac-
tory expressions do not exist. For this section, I will describe the formulation of [Baek 2006].
Suppose there is a homeostatic stress σh, and homeostatic mass production value rkh.
σcardiac(τ) = J(τ)−1F(τ)Skcardiac(τ)F(τ)
T ,
σk(τ) = mk(τ, τ) · σcardiac(τ)mk(τ, τ) , and finally
rk(τ) = rkh + r
k
h J(τ)Kg
(
σk(τ)− σh
)
(27)
= rkh
(
1+ rkKg(τ)
)
.
The number Kg is a mass growth constant.
Notice that the formula for σk(τ) only calls for mk(τ, t) at time t = τ.
The mass of the material is simply the sum of the contributions of its constituents
plus the contribution of a non-growing elastin. The mass R(t) at time t is a tradeoff between
the decay and production of material:
R(t) = Relastin + ∑
k=1,2
(
RkQ(t) +
tˆ
0
rk(τ)q(t− τ) dτ
)
(28)
where
q(τ) = exp(−Kτ)χ{τ<τmax}(τ) (exponential decay) (29)
or q(τ) = (τ − τmax)2(τ + τmax/2) (cubic decay); and
Q(t) =
1∣∣´ τmax
0 q(τ) dτ
∣∣
τmaxˆ
t
q(τ) dτ (30)
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are decay functions forced to zero by some time τmax. The decay function q defines the
reuptake of fibers and Q is for fibers existing at the start. Both fiber families start with
equal mass: Rk = 12 .
3
The homeostatic growth rate rkh = R
k/´ q ensures healthy arteries are stable. Let us
observe why this is so.
Temporarily, write M1(t) for the mass fraction R1Q(t) +
´ t
0 r
1(τ)q(t− τ) dτ of 1-
fibers. Then
M1(0) = R1Q(0) + 0 = R1 .
Assume r1(τ) = r1 is constant for all time. For T > supp(q),
M1(T) = R1Q(T) +
ˆ T
0
r1q(T − τ) dτ
= 0+ r1
ˆ T
0
q(T − τ) dτ
= r1
ˆ T
0
q(τ) dτ .
If M1(t) is constant for all time, I must have R1 = r1
´ T
0 q. Then the value r
1 =
R1/
(´ T
0 q
)
(which is a valid choice for r1 if
´
q > 0) is a time rate of mass production which
achieves constant mass.
For simulation, q is assumed to be piecewise linear, following the time integration
algorithm. This choice provides the pleasant property that the numeric time integration of
q is exact, and mass fractions are numerically exact.
3 Even with the elastin, fibers will be treated identically: R1 ≡ R2. But the Rk will be less than 12 to take
elastin into account: R1 + R2 + Relastin = 1. The following values are reported in [Humphrey(2) 2002, p. 259] for
canine carotid arteries: collagen dry weight = ~45%; elastin dry weight = ~20%; water wet weight = ~70%. Thus,
Relastin = 2045+20 = .30, and R
1 = R2 = .35. (The Rk do not take water into account.)
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Proof: Suppose q is any decay function, and its values at equally-spaced times
tn = n∆t are written as qn = q(tn). For notational convenience, write
∑
m:n
q =
1
2
qm + qm+1 + · · ·+ qn−1 + 12qn ,
and note
∑
m:n
q+∑
n:p
q = ∑
m:p
q
for m < n < p.
Suppose that for arbitrary q, the sum ∑m:n q is an acceptable approximation to
´
[tm ,tn ] q. Suppose N is large enough that tN > supp(q). Consider r
1h := R1/∑0:N q, a
numerical approximation to the homeostatic value of r1 calculated above. Use
Qh(tn) :=
1
∑0:N q
∑
n:N
q .
Then for any time tn = n∆t, with n ∈ [0,∞), approximating the value of M1(tn)
above leads to
M1h(tn) := R1Qh(tn) + r1h∑
0:n
q
= R1
( 1
∑0:N q
∑
n:N
q
)
+
(
R1/∑
0:N
q
)(
∑
0:n
q
)
=
(
R1/∑
0:N
q
)(
∑
0:n
q+ ∑
n:N
q
)
=
(
R1/∑
0:N
q
)(
∑
0:N
q
)
= R1 .
Thus the claims hold.
Formulas for rk(τ) is a subject of ongoing research. I can modify the growth rate
rk(τ) by adding some function of the wall shear stress. If wssk(τ) is the time-varying
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wall shear stress for k-fibers at a point X, wssh is a homeostatic value of wall shear stress,
and Kwss is a sensitivity constant, then I can define a wall shear stress-induced growth
component as
rkwss(τ) = J(τ)
(
Kwss
wssk(τ)−wssh
wssh
)
.
(In practice, wssk(τ) is only known for select times τ. For simplicity, I shall assume
its value is piecewise constant in time.)
In this case, one might write
rk(τ) = rkh
[
1+ rkKg(τ) + r
k
wss(τ)
]
.
It may be useful to include additional terms to model other growth signals.
The tensor Scardiac is a time average of the Second P-K tensor SFSI for the deforma-
tion computed for the cardiac cycle fluid-structure interaction simulation at the most recent
time prior to time τ. The mass production term rk(τ) is based on a scalar time-average sk(τ)
of the stresses due to a cardiac cycle.
3.10.3 Elastic-only Cauchy stress
When using a compressible material, a material model which achieves a Cauchy
stress depending only on elastic energy is helpful. Particularly, when there is irreversible
strain, but no change in elastic strain, the Cauchy stress should not change.
Use the subscript “fib” to denote quantities associated with the fiber hyperelastic
strain energy function. A subscript “coll” will denote quantities associated with a new,
Cauchy stress-oriented material model. Suppose the combined collagen strain energy re-
sponse Scoll as a multiple of a single fiber’s energy:
Scoll = z Sfib .
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Pushing Scoll forward to σcoll will reveal the mystery of z’s composition. Note
from above in equation (22) that Sfib = 2W ′(λ2el)
1
λ2irr
(M ⊗ M) = sel/λ2irr(M ⊗ M). Also,
decompose J into J = λirrλelλA, where λA = J/λ = J/‖FM‖ represents the change in area
normal to M induced by F.
σcoll = J−1FScollFT
= sel
z
J λ2irr
F(M ⊗M)FT
= sel
z
J λ2irr
(m⊗m)
= sel
z
J λ2irr
λ2 (mˆ⊗ mˆ)
= sel
z
J λ2irr
λ2irrλ
2
el (mˆ⊗ mˆ)
= sel
z
J
λ2el (mˆ⊗ mˆ)
= sel
z
λirrλelλA
λ2el (mˆ⊗ mˆ)
= sel
( z
λirrλA
)
λel (mˆ⊗ mˆ) .
If the scalar part of σcoll is to depend only on elastic quantities, the term z/(λirrλA)
should equal 1. Thus z can equal λirrλA, which in turn equals J/λel. I have achieved a
possible formula for the material response of fibers.
Scoll = (J/λel) Sfib
σcoll = (selλel)(mˆ⊗ mˆ) . (31)
The elasticity tensors for this stress formula are
CcollI JKL = 2
∂Scoll
∂C
= 2Sfib
∂(J/λel)
∂C
+
( J
λel
)
CfibI JKL
≈
( J
λel
)
Sfib
[
C−1 − 1
λ2
(
M ⊗M)]+ ( J
λel
)
CfibI JKL
= Scoll
[
C−1 − 1
λ2
(
M ⊗M)]+ ( J
λel
)
CfibI JKL .
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The push-forward of CcollI JKL is
c
coll
ijk` =
1
J
F iIF jJFkKF`LC
coll
I JKL
≈ σcoll[I − mˆ⊗ mˆ] + (J/λel)cfibijk` .
Particularly, note that ccollijk` depends only on elastic quantities.
To deriveCcollI JKL, I made use of a helpful insight from equation (32). Most of the der-
ivation is mundane, with some heavy grunt work conveniently provided by equation (50)
below, ∂J/∂C = (1/2)JC−1. A few tricks are provided by λ = λelλirr, equation (34), and
the assumption ∆t τrelax:
(2λel)
∂λel
∂C
=
∂λ2el
∂C
=
1
λ2irr
M ⊗M +O
( ∆t
τrelax
)
≈ 1
λ2irr
M ⊗M .
∂λel
∂C
≈ 1
2λel
1
λ2irr
M ⊗M = 1
2λ λirr
M ⊗M .
∂(1/λel)
∂C
= − 1
λ2el
∂λel
∂C
≈ − 1
λ2el
1
2λλirr
M ⊗M = − 1
2λ2λel
M ⊗M .
∂(J/λel)
∂C
≈ 1
2λel
JC−1 − J
2λ2λel
M ⊗M
=
1
2
( J
λel
)[
C−1 − 1
λ2
(
M ⊗M)] . (32)
3.10.4 Growth as elastic–plastic decomposition of deformation gradient
Consider an isotropic, homogeneous elastic material with no fibers. Assume that
growth is considered as a multiplicative decomposition of the overall deformation gradi-
ent.
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Call the initial configuration Ω0, the final configuration Ω, and an intermediate
configuration Ωg. Write
ϕ : Ω0 → Ωg
ϕe : Ωg → Ω .
The mapping ϕ(X) = Xg is thought of as being a “pure” growth mapping, and ϕe(Xg) = x
is a purely elastic mapping. The deformation gradients
G =
∂Xg
∂X
Fe =
∂x
∂Xg
satisfy
F = FeG =
∂x
∂X
.
As a modeling assumption, define the total energy of the system as the elastic
energy:
Ψ =
ˆ
Ωg
ψe(Xg) dVg
where ψe : Ωg → R is the elastic strain energy density in the grown configuration. Growth
is not considered as adding energy: Ωg is considered a (potentially nonphysical) stress-free
configuration for the final body.
Note that the volume elements dV0, dVg, and dv are comfortably related by
dVg = (detG)dV0 ,
dv = (det Fe)dVg = (det Fe)(detG)dV0 = (det F)dV0 .
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A pull-back of Ψ to Ω0 yields
Ψ =
ˆ
Ω0
(detG) ψe(ϕ(X)) dV0
=
ˆ
Ω0
ψ(X) dV0 ,
where I have defined ψ(X) to be the strain energy density associated with the deformation
F:
ψ(X) = (detG) ψe(ϕ(X)) .
This gives
P =
∂ψ
∂F
= (detG) PeG−T .
(In obtaining this result, I made the eminently reasonable assumption that G is indepen-
dent of F—indeed, after time discretization and simplifying numerical assumptions are
made, G is constant.)
A few more observations: S and C take similar forms in terms of their growth and
elastic components:
SI J = (detG) G−1IK Se KL G
−T
LJ ,
CI JKL = (detG) G−1IMG
−1
JNG
−1
KPG
−1
LQ Ce MNPQ .
Utilizing these formulae in the IBVP allows independent growth and elastic defor-
mations to take place.
Let us consider two families of fibers which shall be represented by the distinct
directions a and b in which they point. For simplicity, let us assume ∀X, a 6= b so that
{a, b, a× b} spans R3.
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For scalars g1, g2, and g3, define the growth tensor as diagonal in this coordinate
system.
G = g1(a⊗ a) + g2(b⊗ b) + g3(a× b)⊗ (a× b)
=
 g1 g2
g3

{a,b,a×b}
.
This G should be thought of as acting in the fiber directions, with a third action, g3, con-
trolling volume changes given g1 and g2. The scalars g1 and g2 represent the amounts
of extension (or shortening) in the two fiber directions. The third parameter, g3, is deter-
mined by the increase or decrease of mass of the fibers which is not accounted for in the
extension or shortening. (In general, mass increase is independent of fiber lengthening
[Humphrey(2) 2002].) Growth may vary with time and space, but must be physical:
a = a(X, t) 6= 0
b = b(X, t) 6= 0
a× b 6= 0
g1 = g1(X, t) > 0
g2 = g2(X, t) > 0
g3 = g3(X, t) > 0
detG(X, t) > 0 .
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The strain energy function of fibers acts only in the fiber direction. (This is a mod-
eling assumption.) Consider, for a moment, the strain energy ψa of fibers in direction a:
ψa = (detG) ψae (a · Cea)
= (detG) ψae (a ·G−TCG−1a)
= (detG) ψae
 10
0
 ·
 1/g1 1/g2
1/g3
C
 1/g1 1/g2
1/g3
 10
0

= (detG) ψae
 1/g10
0
 · C
 1/g10
0

= (detG) ψae
 1/g10
0
 · FTF
 1/g10
0
 .
Now suppose that F takes on the special form
F =
 f 1
1

{a,b,a×b}
,
meaning that the deformation is one-dimensional and allowed only in the fiber direction
a = [1, 0, 0]T{a,b,a×b}.
ψa = (detG) ψae
 1/g10
0
 · FTF
 1/g10
0

= (detG) ψae
 1/g10
0
 ·
 f 1
1
 f 1
1
 1/g10
0

= (detG) ψae
 f/g10
0
 ·
 f/g10
0
 .
Thus, if f is initially 1 and g1 becomes different from 1, then maintaining equilib-
rium requires the overall F to scale the material by a factor of g1 in the direction of a so as
to balance the 1/g1 terms. (The determinant of G can be assumed to have remained at 1
throughout.) In fact, this is exactly the same behavior as if the fibers were to lengthen by
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a factor of g1; said another way, the new notion of growth mimics the behavior of chang-
ing the irreversible strain of fibers. So growth here is equivalent to growth via turnover
discussed above, at least in certain situations.
3.10.5 Membrane formulation
A two-dimensional membrane formulation of the theory presented here would
appear as follows:
Firr =
 λ11 λ12λ21 λ22
1

{mˆ1, mˆ2, mˆ1× mˆ2} .
The mˆ = mˆ(x, t) directions may not necessarily be fiber directions, but could be unit vectors
in some frame {mˆ1, mˆ2, mˆ1× mˆ2} defined on the membrane. A membrane model would
have an effect due to shear, which is not present in my fiber model. My formulation takes
the following form, which does not have shear terms λ12 or λ21:
Firr =
 λk=1irr λk=2irr
1

{mˆ1, mˆ2, mˆ1× mˆ2} .
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Chapter 4
Discretization
Having defined my theory, I can proceed to the numerics. I use isogeometric analysis with
hierarchical B-Spline basis functions. A discussion of hierarchical splines can be found in
[Evans 2015]. I use hierarchical B-Splines for their ability to describe organic geometries
well, and for local refinement. I do local refinement in the lesion region. In my simulations
I will use larger, high degree basis functions. This helps avoid some issues with incom-
pressiblility causing bending stiffness.
Time discretization uses Backward Euler, a stable method. I assume the material is
quasi-static because growth happens over a long timescale (weeks to years). Time depen-
dence comes from time-dependent material properties (regional decay of the artery wall).
I use Newton–Raphson convergence. The simulation is dynamic, for better convergence
rates.
The timescale of the problem comes from the rate of change of data, partly defined
by τrelax , the timescale of turnover of collagen fibers. τrelax = 70 days. My timestep is
∆tn 6 1 day, so 0 < ∆tn  τrelax . For Newton convergence, I use a slightly inconsistent
tangent where I ignore any term containing the factor ∆tn/τrelax .
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Figure 17: The body B in the growth and remodeling problem. Boundary conditions are shown.
The material is a neo-Hookean hyperelastic solid supported by fibers. The simulation is quasi-static,
being on a timescale of weeks to decades.
4.1 Spatial discretization
Discretize the spaceΩ0 and Γh intoΩs0 and Γ
s
h0, and denote nodes in the discretized
spaces by A or B. In a slight abuse of notation,1 write NA to represent basis functions.2
Now define
Vh = span{NA : A is an interior node}
Sh = Vh ⊕ (boundary conditions)
as finite-dimensional approximations to V and S. Write
ψh = ψhi ei and ψ
h
i = N
AcAi ∈ Vh ,
ϕh = ϕhi ei and ϕ
h
i = N
BdBi ∈ Sh
in terms of some basis ei as linear combinations of basis functions NA defined at each node.
1 For higher-order approximations, there are multiple basis functions for each node. Therefore, A in “NA”
ranges over a different (larger) set than A in “node A.” There is a natural correspondence from one to the other,
so confusion should not arise.
2 Note that NA 6= N 6= N I . The first is a basis function at node A, the second is the unit normal in the material
description, and the third is the I-th component of the second.
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With this notation the Galerkin formulation of (GNR, W) is
(GNR, G)
 Given g, h, findϕ
h ∈ Sh such that for all ψh ∈ Vh ,(
ψhi,J , F iISI J
)
Ω0
=
(
ψhi , JhF
−T
iI N I
)
Γh0
,
After factoring cAi , the constitutive law of (GNR, G) becomes, for each i = 1, 2, 3,(
∂NA
∂X J
, F iISI J
)
Ω0
−
(
NA, JhF−TiI N I
)
Γh0
= 0 , (33)
where X J is the J-th coordinate of X and the residual RAi is the residual in the i-th direction
at node A. The space Ω0 refers to the reference configuration; Γh0 is the Neumann bound-
ary of the artery in the reference configuration. The displacement UBj is the displacement
in the direction j at node B.
Mapping the integrals into Gauss space, where integration is performed, provides
the following. The volumetric term of the residual is(
∂NA
∂X J
, F iISI J
)
Ω0
=
ˆ
Ω0
(∂NA
∂X J
F iISI J
)
dVX
=∑
e
ˆ
e
(∂NA
∂X J
F iISI J
)∣∣∣
X=X(ξ)
∣∣∣dX
dξ
∣∣∣ dVξ
=∑
e
ˆ
G3
(∂NA
∂X J
F iISI J
)∣∣∣
X(ξ(g))
∣∣∣dX
dξ
(
ξ(g)
)∣∣∣∣∣∣ dξ
dg
∣∣∣ dVg
=∑
e
∑
gp∈G3
(∂NA
∂X J
F iISI J
)∣∣∣
X(ξ(gp))
∣∣∣dX
dξ
(
ξ(gp)
)∣∣∣∣∣∣ dξ
dg
(gp)
∣∣∣ gwt(gp) ,
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where the functions
∣∣ dX
dξ
∣∣ and ∣∣ dξdg ∣∣ are volumetric Jacobians. Marked with the variable
names from the code, this term is(
∂NA
∂X J
, F iISI J
)
Ω0︸ ︷︷ ︸
RHSGu
= ∑
e↑
iel
∑
gp∈G3︸ ︷︷ ︸
Localto−
Global_3D_u
(∂NA
∂X J
F iISI J
)∣∣∣
X(ξ(gp))︸ ︷︷ ︸
(body forces: shgu×fi)
+ shgradgu×Ftens×Stens
∣∣∣dX
dξ
(
ξ(gp)
)∣∣∣︸ ︷︷ ︸
DetJ
∣∣∣ dξ
dg
(gp)
∣∣∣︸ ︷︷ ︸
da
gwt(gp)︸ ︷︷ ︸
gwu(igauss)
×gwv(jgauss)
×gww(kgauss)︸ ︷︷ ︸
gwt
.
Similarly, the boundary term of the residual is
(
NA, JhF−TiI N I
)
Γh0
=
ˆ
Γh0
NA JhF−TiI N I dAX
=∑
f
ˆ
 fh
(
NA JhF−TiI N I
)∣∣∣
X=X(ξ)
∣∣∣dφ f
dξ
∣∣∣ dAξ
=∑
f
ˆ
G2h
(
NA JhF−TiI N I
)∣∣∣
X(ξ(g))
∣∣∣dφ f
dξ
(
ξ(g)
)∣∣∣∣∣∣dγ f
dg
∣∣∣ dAg
=∑
f
∑
gp∈G2h
(
NA JhF−TiI N I
)∣∣∣
X(ξ(gp))
∣∣∣dφ f
dξ
(
ξ(gp)
)∣∣∣∣∣∣dγ f
dg
(gp)
∣∣∣ gwt ,
= ∑
f
↑
ifac
∑
gp∈G2h︸ ︷︷ ︸
Localto−
GlobalB_3D_u
(
NA JhF−TiI N I
)∣∣∣
X(ξ(gp))︸ ︷︷ ︸
shbu×traction
∣∣∣dφ f
dξ
(
ξ(gp)
)∣∣∣︸ ︷︷ ︸
Jb_em
∣∣∣dγ f
dg
(gp)
∣∣∣︸ ︷︷ ︸
da
gwt︸︷︷︸
gw(igaussb)
×gw(jgaussb)︸ ︷︷ ︸
gwt
,
where the functions
∣∣∣ dφ fdξ (ξ)∣∣∣ and ∣∣∣ dγ fdg (g)∣∣∣ are the Jacobians of the surface mappings
G2 →  f → Γ0
G2h →  fh → Γh0
induced by φe and γe, and where the corresponding “Neumann” surfaces for the element
and Gaussian spaces are  fh = (φ f )−1(Γh0) and G2h = (γ f )−1(
f
h).
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4.2 Time discretization of adaptive irreversible strain
I use a simple scheme for time discretization. For the below, n refers to a value at
the previously-computed timestep, and n+ 1 indicates a value at the new timestep. Here
is the order of the calculations:
postulated strain rate: λ˙irrn+1 = λ˙
irr(xn+1, tn+1)
time integration: λirrn+1 = λ
irr
n + λ˙
irr
n+1∆tn+1
fiber direction: mn+1 = Fn+1 M
elastic strain: λeln+1 =
λn+1
λirrn+1
, λn+1 = ‖mn+1‖
seln+1 = 2W
′
fib
(
(λeln+1)
2)
collagen Cauchy stress scalar: an+1 = seln+1(λ
el
n+1)
2/Jn+1 , Jn+1 = det Fn+1
collagen Cauchy stress tensor: σfibn+1 = (an+1)(mˆn+1 ⊗ mˆn+1), mˆn+1 = mn+1/‖mn+1‖
The update for the pseudoelastic limit comes from the postulated formula for the
flow rule λ˙irrn+1 = 〈φn+1〉/τrelax where φn+1 = σn+1/kn+1 − 1. Solving for kn+1 gives
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pseudoelastic limit: kn+1 =
{
σn+1/(λ˙irrn+1τrelax + 1) if λ˙
irr
n+1 > 0 ,
kn otherwise.
k˙n+1 = (kn+1 − kn)/∆tn+1
irreversible hardening: k˙irrn+1 = λ˙
irr
n+1H
irr
lesion progression: k˙lesn+1 = k˙
irr
n+1 − k˙n+1
= k˙irrn+1 − σn+1/(λ˙irrn+1τrelax + 1)
= k˙les(σn+1, λ˙irrn+1, xn+1, tn+1)
time integration: keln+1 = k
el
n + k˙
el
n+1∆tn+1
kirrn+1 = k
irr
n + k˙
irr
n+1∆tn+1 .
4.2.1 Consistent tangent for time-discretized problem
Computing a consistent tangent is complicated, but useful for Newton–Raphson
convergence. Briefly, consider the 2nd Piola–Kirchhoff stress as a function of the square of
the elastic part of the strain: S = S(λ2el) = S(λ
2/λ2irr). This makes usage of the chain rule
easier. (The notation here for squares of strains is crude but effective: λel 2n+1 = λ
el
n+1λ
el
n+1
and λirr 2n+1 = λ
irr
n+1λ
irr
n+1.)
Suppose I am at timestep tn+1. Suppose the amount of irreversible strain at the pre-
vious timestep was λirrn , and that I am in the case where there is no additional irreversible
strain this timestep. That is to say, λirrn+1 = λ
irr
n , and
λeln+1 = λn+1/λ
irr
n+1 = λn+1/λ
irr
n .
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Conveniently, λirrn is a constant at time tn+1. Then the algorithm calls for a 2nd Piola–
Kirchhoff stress of
Salgon+1 = S(λ
el 2
n+1) = S(λ
2
n+1/λ
irr 2
n ) .
Then its derivative with respect to Cn+1 becomes
2
∂Salgon+1
∂C
= 2
dS(λel 2n+1)
d(λel2n+1)
∂(λel 2n+1)
∂C
= 2S′(λel 2n+1)
∂
∂C
(λ2n+1/λ
irr 2
n )
= 2S′(λel 2n+1)
1
λirr 2n
(Mn ⊗Mn)
= 2S′(λel 2n+1)
1
λirr 2n
(Mn ⊗Mn)
= 2S′(λel 2n+1)
1
λirr 2n+1
(Mn ⊗Mn) .
In the case of adaptive irreversible strain, the new irreversible strain amount is
prescribed. In the case of non-adaptive irreversible strain, compute “trial” stress using the
amount of irreversible strain from the last timestep:
Strn+1 = S(λ
2
n+1/λ
irr 2
n )
σtrn+1 = mn+1 ·
(
Fn+1Strn+1F
T
n+1
)
mn+1
= (Fn+1Mn+1) · Fn+1Strn+1FTn+1(Fn+1Mn+1)
= (Cn+1Mn+1) · (Strn+1Cn+1Mn+1) .
Then there is additional irreversible strain when
αn+1 =
〈
σtrn+1
ktrn+1
− 1
〉
=
(
σtrn+1
ktrn+1
− 1
)
> 0 .
λirrn+1 = λ
irr
n + αn+1(∆tn/τrelax)
kirrn+1 = k
irr
n + αn+1(∆tn/τrelax)H
irr
n+1 .
Sn+1 = S(λ2n+1/λ
irr 2
n ) .
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The derivative of the algorithmic 2nd P–K tensor becomes
C
algo
n+1 = 2
∂Salgon+1
∂Cn+1
= 2
dS(λel 2n+1)
d(λel2n+1)
∂(λel 2n+1)
∂Cn+1
= 2S′(λel 2n+1)
∂
∂Cn+1
(λ2n+1/λ
irr 2
n+1)
= 2S′(λel 2n+1)
[
1
λirr 2n+1
(Mn ⊗Mn)− 2 λ
2
(λirrn+1)
3
(
∆tn
τrelax
)
︸ ︷︷ ︸
1
(
1
ktrn+1
)(
∂σtr
∂Cn+1
)]
≈ 2S′(λel 2n+1)
1
λirr 2n+1
(Mn ⊗Mn) . (34)
The approximation in the last line yields the same formula as for the earlier case of no new
irreversible strain. The approximation is best when 0 < ∆tn  τrelax. The other terms do
not go to zero with a decrease in ∆tn, nor do they blow up. In addition, computation of the
term ∂σtr/∂Cn+1 is costly.
Using this slightly inconsistent tangent works well.3
3 Newton convergence even with the consistent tangent can still have problems due to the discontinuity
introduced by the bracket 〈·〉 in the definition of α. To solve this, I round off the corner of the bracket, like so:
Suppose
R > 0
a = R cot(3pi/8)
b = a cos(pi/4)
y =
√
R2 − (x+ a)2 .
The radius of the fillet is R, the arclength to be swept is pi/4, and the fillet lies within the interval (−a, b).
〈x〉R =

0 x 6 −a
R− y −a < x < b
x x > b ,
-a b
R
d〈x〉R
dx
=

0 x 6 −a
a+x
y −a < x < b
1 x > b . -a b
1
The final curve is C1. To minimize the effect of the rounded bracket on the elastic regime, take R  1. I are
reassured of the friendliness of the rounded bracket by its behavior in the limit: as R→ 0, 〈·〉R → 〈·〉0 = 〈·〉, both
pointwise and in mean. For this smoothing to have practical value, the (possibly adaptive) step size should create
increments (αn+1 − αn) smaller than b+ a when αn is near the fillet.
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4.3 Newton-Raphson scheme
The BVP (GNR, G) is nonlinear; F, S, and J = det F all depend on the motion ϕh
(as does Mkref, used below). To solve equations (33), I use the Newton-Raphson technique.
The Newton-Raphson scheme for this problem becomes
1. Choose relative and absolute error tolerances εrel, εabs > 0, a norm ‖ · ‖ of the resid-
ual, and begin with iteration number ν = 0. Choose an initial guess
(
UBj
)ν for the
displacement.
2. Build the residual
(
RAi
)ν (the residual in the i-th direction at node A) by evaluating
equation (38) at guess
(
UBj
)ν.
Build
( ∂RAi
∂UBj
)ν in the same way.
3. Suppose there is a solution to the following linear finite-dimensional problem and
solve the expression for
(
∆UBj
)ν:
(∂RAi
∂UBj
)ν(
∆UBj
)ν
= −(RAi )ν . (35)
4. Update the guess to
(
UBj
)ν+1
=
(
UBj
)ν
+
(
∆UBj
)ν. Increment ν.
5. Repeat steps 2–4 until
∥∥(RAi )ν∥∥ < εabs, or ∥∥(RAi )ν∥∥/∥∥(RAi )0∥∥ < εrel.
When it does, define UBj as
(
UBj
)ν.
6. Obtain the displacement U = NBUB, motion ϕt(X) = U(X) + X, and deformation
gradient
F =
∂U
∂X
+ I =
∂NB
∂X
UB + I .
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4.4 Data recovery procedure
Interesting data values such as stresses, mass growth, and fiber directions will only
be calculated exactly at the gauss points on each element (or face). In order to extrapolate
these values to the nodes (control points), I will use a least squares approximation tech-
nique. This method is used for computational efficiency at the expense of accuracy. The
computed values are used for visualization only.
Suppose f i(X) is the i-th component of some vector-valued function f (X) =
f i(X)ei, defined on the reference configuration Ω0, and whose exact values are known
only at Gauss points: f i
(
X(ξ(gp))
)
= f gpi .
Values of f (X) typically represent interesting data for the current configuration,
and may perhaps be more properly represented as f (X, t), but let us drop the time depen-
dence for the sake of clarity; t shall not change in what follows. The same procedure will
be applied at each timestep.
The goal of the stress recovery procedure is to find real values f Bi for each node B
and direction i such that the approximation f hi (X) = N
B(X) f Bi interpolates the exact val-
ues known at gauss points: f hi
(
X(ξ(gp))
)
= f gpi .
Converting to weak form as above gives an equation for each node A and direc-
tion i; namely, (
NA, NB f Bi
)
Ω0
=
(
NA, f i
)
Ω0
,
leading to the Newton-Raphson equation
(
NA, NBδij
)
Ω0
(
∆ f Bj
)
= −
(
NA, NB f Bi − f i
)
Ω0
.
(See equation (35).) Approximating the integrals with Gaussian integration leads to some-
thing like (36) in Figure 18.
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The process for recovery of boundary data is identical, with the change that inte-
grals are performed over faces (Γ0) instead of volumes (Ω0). See Figure 19.
4.5 Derivative of the residual RAi
Taking the derivative of RAi with respect to U
B
j gives the following, where C =
2 ∂S/∂C.
RAi =
(
∂NA
∂X J
, F iISI J
)
Ω0
−
(
NA, JhF−TiI N I
)
Γh0
. (38)
∂RAi
∂UBj
=
(
∂NA
∂X J
, δij
∂NB
∂X I
SI J + F iICI JKLF jL
∂NB
∂XK
)
Ω0
−
(
NA, Jh
(
F−1Kj
∂NB
∂XK
F−1Ii − F−1I j
∂NB
∂XK
F−1Ki
)
N I
)
Γh0
. (39)
Let us confirm this result. It is important to have every index verifiably correct to recognize
typos and debug code.
I slowly build up to the derivatives of the strain energy functions, the residual of
a linear momentum equation, and viscoplasticity equations. I use a mix of vector notation
and index notation. While vector notation is often elegant and beautiful, some expressions
are insufficiently described without explicit indices. I also use the Einstein summation
convention. In the summation convention, there is an implied sum over repeated indices:
FSFT =
3
∑
i=1
3
∑
I=1
3
∑
J=1
3
∑
j=1
F iI SI J FTJ j (ei ⊗ ej) = F iI SI J FTJ j (ei ⊗ ej) .
The first equality demonstrates the conversion from vector to index notation; the second
equality demonstrates the Einstein summation convention; ei for i = 1, 2, 3 are the basis
vectors.
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4.5.1 General formulas
I begin with simple expressions that are needed later.
The derivative of the trace of a matrix A with respect to A:
∂ tr A
∂Aij
=
∂
∂Aij
Akk = δikδjk = δij . (40)
The derivative of the trace of the square of a matrix A with respect to A:
∂ tr(A2)
∂Aij
=
∂
∂Aij
(
Ak`A`k
)
= δikδj`A`k + Ak`δi`δjk = Aji + Aji = 2 Aji . (41)
∂ tr(A2)
∂A
= 2 AT . (42)
It is important to recognize that differentiation with respect to symmetric tensors is
not the same as differentiation with respect to a nonsymmetric tensor. A symmetrization
must occur over the differentiated indices. This will become apparent as the next few
formulas emerge.
The derivative of a real-valued function f (C) of a symmetric tensor C
with respect to its argument:
∂ f (C)
∂Cij
=
[∂ f (A)
∂A
]
(ij)
∣∣∣A=C . (43)
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The derivative of a symmetric tensor C with respect to itself:
∂Ckl
∂Cij
=
[
δkiδl j
]
kl(ij)
=
1
2
(
δkiδl j + δkjδil
)
(44)
6=
[
δkiδl j
]
klij
.
Proof: Taking f (C) = Ckl in (43) above,
∂Ckl
∂Cij
=
[∂Akl
∂Aij
]
(ij)
∣∣∣A=C
=
[
δkiδl j
]
kl(ij)
∣∣∣A=C
=
[
δkiδl j
]
kl(ij)
=
1
2
(
δkiδl j + δkjδil
)
.
The derivative of the trace of the square of a symmetric matrix C with respect to C:
∂ tr(C2)
∂Cij
= 2C(ji) = 2Cij . (45)
The derivative of the determinant of a matrix A with respect to A:
∂
∂Aij
det A = (det A)(A−T)ij . (46)
For a proof of this difficult result, see, for example, Example 1.10 on page 41 of
[Holzapfel 2000].
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The derivative of the inverse of a (nonsingular) matrix A with respect to A:
∂A−1ji
∂Amn
= −A−1jm A−1ni . (47)
Proof: First, note that A−1jp Apk = δjk, and so if ( )
 is some kind of derivative, then
taking the ( ) derivative with respect to both sides and then right multiplying by A−1 gives
(A−1jp )
 Apk + A
−1
jp (Apk)
 = 0
(A−1jp )
 Apk A
−1
ki + A
−1
jp (Apk)
 A−1ki = 0
(A−1jp )
 δpi + A−1jp (Apk)
 A−1ki = 0 .
Using ( ) = ∂/∂Amn, I see
(A−1ji )
 + A−1jp (Apk)
 A−1ki = 0
∂A−1ji
∂Amn
+ A−1jp δpm δkn A
−1
ki = 0
∂A−1ji
∂Amn
= −A−1jm A−1ni .
The derivative of the inverse of a (nonsingular) symmetric matrix C
with respect to C:
∂C−1ji
∂Cmn
= −1
2
(
C−1jm C
−1
ni + C
−1
im C
−1
nj
)
. (48)
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Proof: For each i and j, apply (47) and (44), using f (C) = C−1ji . The symmetrization
occurs over m and n, but not i or j:
∂C−1ji
∂Cmn
=
∂ f (C)
∂Cmn
=
[∂ f (A)
∂A
]
(mn)
∣∣∣A=C
=
[ ∂A−1ji
∂Amn
]
(mn)
∣∣∣A=C
=
[
−A−1jm A−1ni
]
(mn)
∣∣∣A=C
= −1
2
(
A−1jm A
−1
ni + A
−1
im A
−1
nj
)∣∣∣A=C
= −1
2
(
C−1jm C
−1
ni + C
−1
im C
−1
nj
)
.
4.5.2 Elasticity formulas
The derivative of the determinant J2 = detC with respect to C = FTF:
∂J2
∂C
= J2C−1 . (49)
Proof: Equation (46) gives us ∂J
2
∂C =
∂detC
∂C = (detC)C
−T = J2C−1 .
The derivative of the determinant J = det F with respect to C = FTF:
∂J
∂C
=
1
2
JC−1 . (50)
Proof: Observing ∂J
2
∂C = 2J
∂J
∂C and equating it with (49) yields the result quite neatly.
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The derivative of the inverse J−1 = 1/(det F) with respect to C = FTF:
∂J−1
∂C
= − 1
2J
C−1 . (51)
The derivative of the deformation gradient F with respect to displacement U:
∂F iI
∂UBj
=
∂NB
∂X I
δij . (52)
Proof: First, note that
F iI =
∂
∂X I
ϕi =
∂
∂X I
(I +U i) = δiI +
∂U i
∂X I
,
and I am writing NA = NA(X) as the basis functions at each node A:
U i = NAUAi .
Then
∂
∂UBj
F iI =
∂
∂UBj
(
δiI +
∂U i
∂X I
)
= 0+
∂
∂UBj
∂
∂X I
U i =
∂
∂X I
∂
∂UBj
U i
=
∂
∂X I
∂
∂UBj
(NAUAi ) =
∂
∂X I
NA
∂
∂UBj
UAi =
∂NA
∂X I
δijδAB
=
∂NB
∂X I
δij .
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The derivative of the inverse of F with respect to displacement:
∂F−1Ii
∂UBj
= −F−1I j
∂NB
∂XK
F−1Ki . (53)
Using ( ) = ∂/∂UBj as in the proof of (47), and equation (52), I see that
∂F−1Ii
∂UBj
= −F−1Ip
∂NB
∂XK
δpjF−1Ki = −F−1I j
∂NB
∂XK
F−1Ki .
The derivative of the determinant J = det F with respect to displacement:
∂J
∂UBj
= J(F−T)jQ
∂NB
∂XQ
. (54)
Proof: This follows easily from the formula (46) for the derivative of the determi-
nant function.
In particular,
∂J
∂UBj
=
∂J
∂FpQ
∂FpQ
∂UBj
= J(F−T)pQ δpj
∂NB
∂XQ
,
giving the desired result.
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The derivative of the Cauchy-Green strain tensor C = FTF
with respect to F:
∂CKL
∂FpQ
=
∂
∂FpQ
(F iKF iL) = δpiδQKF iL + F iKδpiδQL = δQKFpL + FpKδQL . (55)
The derivative of the Second Piola-Kirchhoff tensor S
with respect to displacement:
∂SI J
∂UBj
= CI JKLF jL
∂NB
∂XK
. (56)
Proof: Note that CI JKL is equal to ∂SI J/∂EKL = 2 ∂SI J/∂CKL. Then use the above
formulas to achieve
∂SI J
∂UBj
=
∂SI J
∂CKL
∂CKL
∂FpQ
∂FpQ
∂UBj
=
1
2
CI JKL
(
F jL
∂NB
∂XK
+ F jK
∂NB
∂XL
)
.
ButC enjoys minor symmetry (generously provided by the symmetry ofC): CI JKL =
CI JLK. Thus renaming index K as L and index L as K gives
∂SI J
∂UBj
=
1
2
CI JKL
(
F jL
∂NB
∂XK
)
+
1
2
CI JLK
(
F jK
∂NB
∂XL
)
=
1
2
CI JKL
(
F jL
∂NB
∂XK
)
+
1
2
CI JKL
(
F jL
∂NB
∂XK
)
= CI JKL
(
F jL
∂NB
∂XK
)
.
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Then by plugging in the results above, I directly derive
The derivative of the residual
RAi =
(
∂NA
∂X J
, F iISI J
)
Ω
−
(
NA, JhF−1Ii N I
)
Γ
with respect to displacement:
∂RAi
∂UBj
=
(
∂NA
∂X J
, δij
∂NB
∂X I
SI J + F iICI JKLF jL
∂NB
∂XK
)
Ω
−
(
NA, Jh
(
F−1Ii
∂NB
∂XK
F−1Kj − F−1I j
∂NB
∂XK
F−1Ki
)
N I
)
Γ
. (57)
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Chapter 5
Building smooth meshes for isogeometric analysis
In the context of this work, the term “model” refers to a mathematical representation of
the geometry of a given object. In particular, the representation—the model—must be
a representation on which one can perform computations. This restriction distinguishes
modeling from visualization, which can rely on the observer’s ability to extract informa-
tion from a representation that is obscured. Visual representations can tolerate high levels
of noise, registration mismatches, confounding of nearby objects, and imprecise measure-
ments. Models for computation cannot. Objects I model for this work will be either organs
in the body (a section of artery or perhaps a heart) or idealized shapes reminiscent of such
organs.
Reference to a modeling “pipeline” indicates a specific procedure of modeling an
organ from noninvasive medical imaging data.
81
Figure 21: Representative images from PET scans. PET scans show organ function. As with CT or
MR, PET can show three dimensional data. See, for example, https://en.wikipedia.org/wiki/
File:PET-MIPS-anim.gif. [Langner 2010]
5.1 Choosing medical image modalities
There are many medical imaging technologies available for engineering analysis.
Carefully choosing a format which is conducive to the analysis to be done is important,
and translating engineering terminology and needs into clinical terminology takes many
discussions. Here I explore various imaging technologies and their uses in engineering
analysis and their suitability for this work in particular.
5.1.1 Positron Emission Tomography (PET)
PET scans provide physiological information about the organ in question (usually
the heart, brain, or cancerous tumors): “Which parts are getting blood, and how much do
they get?” or “We think you have tumor X. Tracer Y, we find, concentrates primarily in
type X tumors. We will inject tracer Y, then take a picture.” Physiological information (ie,
“Is this tissue metabolically active?”) is as opposed to anatomical information (ie, “What
tissue is right here?”).
A radioactive isotope is incorporated with special sugars that concentrate in the
desired tissues, and is injected into the bloodstream. The sugars go to the right places, be-
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cause after fasting the body (healthy tissue) isn’t able to process the sugars, while cancerous
tissue can!
The isotope decays, emitting a positron. When the positron strikes an electron,
they annihilate, emitting two gamma particles that travel in exactly opposite directions.
(e+ + e− = 2γ.) Detectors backsolve to find the decaying isotope’s position. Integrating
and normalizing gives images something like Figure 21.
Diseased metabolism and tumors are immediately apparent with abnormal dis-
tribution of the isotope. This is the hallmark of good visualization: that it doesn’t take a
doctorate to understand the image’s basic revelations.
PET is capable of good quality images—its resolution is ~5mm. It has some data
resolution limitations:
• Positrons can travel a few millimeters before finding an electron.
• The gamma rays are not detected as exactly 180 degrees apart. This occurs if one of
the gamma rays is deflected into another detecting sensor. In this case, the machine
will mis-calculate the annihilation location.
• Detector resolution is itself limited.
A somewhat recent improvement for tumor detection in PET scanning is to include a CT
scanner in the same device. (Not all PET imaging techniques use CT.) The CT scan pro-
vides anatomical information, and the fact that they are acquired together permits easy
registration of the two datasets. A physician thus can tell clearly what anatomy produced
the bright or dim spot, rather than guess based on experience. This isn’t always easy: for
instance, it’s subtle but crucial to know whether a tumor is above or below the diaphragm.
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Software clinicians use to read PET/CT scans display both the PET and CT image
side by side; and there are two cursors, hovering over the same spot in each image.
From an oncological perspective, good tracers are highly nontrivial to create. All
of these things must be accomplished:
• binding the tracer to a sugar (or other metabolically active material)
• finding a sugar that is taken up by a cancerous tumor, or, more commonly:
finding a type of tumor that takes up your sugar (the tumor should be one I can’t
already image better another way)
• developing a procedure (such as fasting for 24 hours) which causes the sugar to be
taken up selectively by the tumor
• constructing a detector sensitive enough for your application
• mass-producing the above solution.
Each of the above tasks is probably worth a PhD or two (or five). The way we do the above
for most tumors is pretty interesting, but beyond the scope of this work.
The half-lives of the isotopes used in PET scanning are short:
isotope half-life medical applications(min)
Rubidium-82 1.25 cardiac
Oxygen-15 2.1 neuro, some cardiac application
Nitrogen-13 10 cardiac
Carbon-11 20.4 cardiac
Fluorine-18 110 cardiac, neuro, skeletal, esp. for distant cyclotrons
Patients are done “glowing” by the time they leave the facility.
5.1.2 Single Photon Emission Computed Tomography (SPECT)
SPECT imaging, like PET, provides physiologic information of the body by detect-
ing the decay of a radioactive substances. A radioactive isotope is injected into the body,
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and the protons emitted when it decays are detected. PET and SPECT are extremely similar,
and are therefore used in essentially the same fashion. (For instance, SPECT is also coupled
with CT.) Pointless debates occasionally rage over the value or cost of SPECT versus PET,
and most institutes will choose to support only one. But every major medical center must
have both available, as both are crucial; they use different classes of radiotracers, which are
taken up better by different classes of tumors.
5.1.3 Magnetic Resonance Imaging (MRI)
MRI (or MR) is a technique for retrieving anatomical data about the body. “What
tissue lies at position (x, y, z)?” (Recall that PET and SPECT illuminate physiologic data
about the body. “Is this tissue metabolically active?”) MR can acquire fluid velocity data,
too, if pressed, and can show displacements of solids (in a limited manner). MR’s spatial
and temporal resolution is excellent (~1mm3 spatially and ~40ms temporally, with research
devices achieving ~1um3 spatially), it has enviable soft tissue contrast, is moderately free
from artifacts, and is nontoxic. Unfortunately, it’s expensive ($3-4M, plus $4-700K/yr in
electricity and upkeep), time-consuming, heavy, and loud. (See Table 20 on page 83.)
Major MR departments, especially in competitive environments (defined by geog-
raphy or research area), often upgrade each machine every three years. The old machines
go to other hospitals, other countries, and veterinarians.
MR imaging of the brain creates exceptionally clear images quickly. This is because
the brain doesn’t move. Cardiac MR suffers from registration artifacts caused by the heart’s
movement. Only a small portion of the heart can be imaged during the short period of rest
between heartbeats, and because the heart doesn’t return to exactly the same position each
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time, and because people need to breathe (which moves the heart around). I once heard a
Cardiac MR researcher quip, “MR is the worst modality for scanning the heart.”
Creating a good scan uses tricks and takes a long time (forty-five minutes). The
main tricks are detecting the location of the diaphragm and the QRS complex of the elec-
trocardiograph (EKG); when both of them are in just the right place, scanning is done. This
is a free-breathing scan, where the patient just lies there, preferably asleep (but usually
bored, and sometimes claustrophobic). There are also breathhold scans.
MRI devices work by creating huge magnetic fields around the patient’s body,
aligning a mere O(.001%) of the protons in the body, and detect the tiny magnetic fields
produced as the protons realign with the Earth. MR detects all atoms with an odd number
of protons, which means it detects hydrogen. (No other atom with an odd atomic weight
occurs in the body in any significant concentration.) The vast majority of hydrogen exists in
either water or fat. So we distinguish soft tissues by their relative concentrations of water
and fat, and we tune the MR machine’s sequences to improve the distinction between the
two. Bone and air are easily distinguished, as are blood, muscle, and most other tissues.
The magnetic field together with radiofrequency pulses “tag” the protons with
their location in space, and the location is read back a short time later. This is a way of
acquiring velocity data (for blood) or mechanical motion (for the heart). For a still image of
the heart, the tagging and reading are done while the heart is at rest. Naturally, heart rate
control is a routine preparation for MRI. The time interval between tagging and reading
is not arbitrary. (For more information, read about “relaxation time” and “T1- and T2-
weighted imaging” in any relevant resource. The time intervals used are prescribed by the
organ being observed.
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As with CT, contrast injection is routinely used to highlight certain anatomy or
physiology. Clinically-useful tricks allowed with contrast injection number in the dozens;
research tricks in the thousands.
MR, being safe, is a popular research tool. It is generally used for neurologic ap-
plications for its soft tissue contrast, where CT and PET/SPECT are entirely lacking. Grey
matter is largely water, and white matter is largely fat. For cardiac applications, MR is
generally used for anatomic reconstruction, perfusion, and viability.
The fields produced by the machine are believed not to be harmful to humans.
That said, pacemakers could malfunction—they are, in fact, an absolute contraindication.
Not only could the pacemaker’s electronics malfunction temporarily or permanently due
to MR, but the changing magnetic field could induce electric current in the pacemaker
leads. Either could to improper pacing shocks, causing fatal arrhythmia. Implanted or
embedded metal will typically heat up or move, at least a little bit. Pregnant women, as a
precaution, should avoid MR, especially in the first trimester; plenty of better-understood
alternatives exist.
MR artifacts are anisotropic, colloquially referred to as “graininess.” Anisotropic
diffusion filtering is the standard fix.
Metal implants disrupt the magnetic field, causing “washout” artifacts. Even a thin
wire can create a black cylinder in one’s dataset an inch in diameter. Special “MRI-safe”
versions of implantable devices are frequently used. A nickel titanium blend, Nitinol, is
the frontrunning material.
The huge magnetic fields produced by the magnet switch on and off very rapidly.
Especially in high-power magnets, this can cause peripheral nerve stimulation. (The pace-
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maker restriction is primarily due to the ability of the magnetic fields to generate pacing-
level currents in the pacemaker leads. The pacemaker circuitry itself can also become de-
stroyed.) Patients undergoing MR report twitching sensations, particularly in the extremi-
ties.
I had an MRI scan performed for the purpose of creating the model in Figure 1.
Myself, I knew when the machine was scanning me, because I could “hear” the changing
magnetic field—before it made a noise—through a sensation in the base of my neck. Bzzt!
Bzzt! Bzzt!
The gradient field is zero at the center of the magnet, and increases linearly with
distance along the body axis (or whatever axis one chooses). Therefore, when scanning the
brain, these new high-powered magnets can generate current in the heart. This situation is,
to put it mildly, arrhythmogenic. It is common around the world to prescribe safety limits
on the amount of change |dB/dt| of the magnetic field B per unit time.
The magnetic fields produced by the magnet cause the coils producing them to
warp, creating noise. Procedures can be up to 100–130 dB, which is at or above the thresh-
old of pain. (Think of standing fifty feet from a jet engine at takeoff.) New machines
are quieter, but patients still wear either earplugs or headphones, bringing the noise level
down to that of a nightclub or a busy restaurant. High-quality acoustic insulation, active
noise cancellation, and mandated limits on dB/dt all help. Modern MR installations pro-
vide virtual reality goggles so patients can watch a movie.
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5.2 Segmentation of patient-specific organ geometries
As preliminary efforts, I modeled the heart (Figure 1 on page 2), abdominal aortic
aneurysms (Figure 4b on page 8), thoracic cavity (Figure 3 on page 6), coronaries (Figure 24
on page 97), pulmonary arteries (Figure 25 on page 98), and many other organs.
5.3 Heart modeling pipeline
As a preliminary project for this work, I built an accurate (1 mm resolution) 3D
model of a living human heart (see Figure 1 on page 2). I collected software tools for
physical modeling of medical data, and devised a data flow pipeline to link them into a
system for modeling organs in the body (see Figure 7 on page 14).
The work elucidated many challenges involved in modeling organs from nonin-
vasive imaging. It demonstrated the utility of building patient-specific models by empha-
sizing differences between patients: the branching pattern of the coronaries, location and
numbers of pulmonary veins, and the thickness, size, and shape of the left ventricle.
One of the most important challenges in medical image modeling is finding an
imaging modality which has the capabilty to provide the information required. Essentially
all clinical imaging is either physiologic in nature or designed for visualization. Obtain-
ing a dataset of blood vessles with anatomic data involves either contrast-enhanced CT,
which provides only blood boundaries, or MRI, which contains significant noise. In ad-
dition, people who are knowledgable of imaging protocols for visualization are usually
not knowledgable of the issues in geometric modeling, and vice-versa. And rather than
abandon clinical visualization, one must recognize the vast understanding of the human
body built with visualizations. Utilizing this in a way that benefits both visualization and
modeling communities is key.
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Once a data set has been obtained, the challenge is to find segmentation techniques
which are both sensitive to the organ being tested and at the same time robust to noise
and registration errors inherent in the modality. For instance, cardiac CT requires multi-
ple heartbeats in which to obtain a picture, and multiple datsets are (imperfectly) fused
into one. (See § 5.6 Coronaries below.) Cardiac MR, on the other hand, has mechanisms
to reduce registration issues, but it suffers from a “graininess” that benefits from careful
application of anisotropic diffusion filtering.
After the organ being modeled has been located within one’s dataset, a geometry
can be made to match. Again, each organ and modality requires a separate technique. For
the heart shown in Figure 1, manual segmentation was used to create a finite element mesh.
5.4 Rapid prototyping
A triangle mesh from image data was fed into a rapid prototyping machine to
create a physical model representing the subject’s heart. A physical model is an extremely
valuable tool for stimulating innovation in computational modeling. A physical version
constructed from the model is one of the few ways to see the organ separated from its
surroundings.
It can be used for visualization as a way for physicians to understand the subtle dif-
ferences a particular patient is presenting which may not have been emphasized with usual
methods. For instance, a cardiologist treating a diabetes patient’s cold foot will glance at a
previously-obtained MRI or CT scan, but make nearly all clinical treatment decisions based
on a catheterization. Catheterization has an advantage over MR and CT in that it can show
the flow rate, as sites of sluggish flow versus good, fast flow. But it can only provide a 2D
projection of the arteries, and the cardiologist rarely makes an effort to observe another an-
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gle because s/he can provide good treatment without the added radiation dose. A physical
model built from the original MR or CT dataset can give all three dimensions quickly and
easily. There is a push lately, with the recognition of vulnerable placques, toward under-
standing the value of knowing a blockage’s three dimensional makeup. A physical model
built with rapid prototyping is cheap, easy, and can help physicians give better care.
It is a teaching tool. The physician can use the physical object to point to, when
discussing the treatment with the patient or a colleague, and the patient can take it home as
a way of continuing to observe the geometry and learn from it. Better patient understand-
ing of treatments and better means of patient-to-friends communication regarding medical
care will stimulate and improve common understanding of medicine.
It is an experimental tool since a researcher can use it to simulate different situa-
tions that cannot be observed by any reliable technique. Exercise physiology, for instance,
is nearly impossible to measure in natural conditions. There are enough difficulties mea-
suring internal blood pressures and flow rates in a person who is still; doing it during
exercise or in a patient’s daily routine is a problem not likely to be solved soon. Physical
experimentation with physiologic variables at exercise levels will improve understanding
of the human body.
5.5 Aortas
I applied the heart pipeline (seen in Figure ??a) to a study of coronary arteries.
The data was anatomical data similar to the sort used for cranial arteries, and from them,
I built a thoracic aorta, abdominal aortas, and I simulated interventions. The segmenta-
tion has been done by hand (from MRI) and with thresholding techniques (from gated CT
angiography).
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Figure 22: Mesh of thoracic aorta from MRI. Different imaging modalities (CT, MR, etc.) give rise to
different segmentation techniques (thresholding, marching cubes, manual segmentation, etc.). This
was a triangle mesh segmented by hand, of the authors’ own aorta. This mesh was used in [Bazilevs].
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Figure 23: Physical model of an abdominal aorta from CT. This was 3D printed using selective laser
sintering (SLS) with a soft rubber-like material. Settings were used such that the material has prop-
erties similar to that of arteries. After printing, the artery tree was infused with a coloring and fixing
agent to take on a red hue and protect and seal the object’s surface. The superior mesenteric artery
and celiac artery trunk are visible, as well as the renal arteries and iliacs. More interesting is that
placque buildup in the internal iliac and renal arteries is also visible.
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Computationally-valid aortic models were built. MRI and (gated) CT are both
suitable for building the models. (See Figure 22 and Figure 23 on the previous page.)
I modeled a throacic aorta from 4D phase-contrast MRI data. The segmentation
was done by hand with a pen tablet using amira, a commercial software package devel-
oped for computing with medical data. The program is pipeline-oriented (See Figure 7b).
It has numerous modules for image processing, including the entire Insight Segmentation
and Registration Toolkit [itk.org]. Its meshing system takes a 3D data set and an arbitrary
selection of pixels (representing the tissue of interest) and outputs a triangular or tetrahe-
dral mesh.
I used amira’s smoothing routines to remove wrinkles, then converted the triangle
mesh to a computationally-ready hexahedral mesh using in-house software. The solid
hexahedral mesh was then summarized by a skeletonization process into a midline and
radii. Branches were represented by branches in the midline. The geometry of the ostia
was approximated using specialized template pieces.
An experiment was set up using this geometry in which flow comparisons were
made between a common-practice medical treatment (placement of left ventricular assist
device output into the descending aorta) and a promising alternative (placement in the
ascending aorta). The experiment confirmed the researchers’ suspicion that the alternate
treatment promoted better flow in the aorta throughout the cardiac cycle. It supported the
findings of a clinical study comparing outcomes of the two alternatives [Kar 2005]. The
result is a convincing argument in favor of performing the alternative treatment.
This demonstrates the utility of applying engineering analysis to clinical problems
and the necessity of doing so for physician buy-in to new treatments.
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5.6 Coronaries
I used a seed-based segmentation technique. A two-dimensional seed was placed
in the first slice, and a region was grown around the seed up to a brightness cutoff; the
cutoff was chosen based on the seed pixel’s brightness.
To extend the selected region in three dimensions, I used the following approach.
The brightest pixel directly below the previous slice’s selected region was chosen as the
seed for the new slice. A two-dimensional region was grown as before, and the process
repeated. I defined the process as complete when the region size went to four pixels or less,
or when the new seed point was darker than the previous cutoff. The process completing
indicated either the artery had curved away, effectively ended, or there was a registration
defect. Manual clean-up was required, as well as smoothing and then a manual distinction
between arteries and veins. See Figure 24 on the following page.
The patency of the lumen is good throughout the coronaries and faithfully depicts
the geometry of the image, including the image’s inaccuracies. Note, for instance, the
registration defect in the LAD past the second branch in Figure 24a; though 64-slice CT
is fast, it is not fast enough to image the entire heart in one pass. Registration defects in
cardiac CT imaging will persist until CT makes at least a fivefold speed increase.
Also notice the jagged lumen in the distal half of the Ramos branch. This shows
that that the contrast agent has diffused into the myocardium, obscuring the branch’s lu-
men. This artifact cannot be removed—indeed, the coronary veins are imaged by timing
the contrast agent’s passage from arteries to myocardium to veins. Two boluses of contrast
agent are given so that, in a single imaging pass, the arteries and veins are both lit.
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The diffusion artifact could possibly be removed after a few test runs for timing
and by using separate imaging passes for the arteries and veins. But this creates two
worse problems: compounded registration issues, and a much higher toxicity from both
the x-rays and the contrast agent. Also, distinguishing those vessels is not clinically useful;
cardiologists let Ramos branches and vessels less than 1 mm fend for themselves.
Tools are being developed to build mesh geometry automatically directly from
medical image data.
I use isogeometric analysis technologies, which properly describe idealized geom-
etries, and are good at representing patient-specific organic structures.
(a) This orientation features the left coronary artery.
Visible is the LAD (at left), LCX (at right), and an un-
usual Ramos branch in the middle. Notice that veins
tend to run alongside arteries. This makes them hard
to distinguish.
(b) The right coronary artery is visible on the left side
of the image, and the large coronary sinus in blue is
adjacent to the aortic root.
Figure 24: Subject-specific coronary arteries from gated contrast-enhanced CT. The coronary arteries
and aortic root are red, the veins blue. Notice the subject has few major diagonal branches off either
the left anterior descending artery (LAD) or left circumflex (LCX); the Ramos branch perfuses the
tissue instead.
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Figure 25: Tetrahedral mesh of pulmonary ar-
teries from MR data using the image processing
portion of the pipeline in Figure 7a. Anisotropic
diffusion filtering was applied to the MR data.
The boundary was defined by a “best fit” to a
surface extracted by thresholding. This mesh
was built for studying inverse problems in hu-
man imaging.
Figure 26: Automatic location of a stenosis in
a user-chosen segment of artery with Philips’
“Computer-Assisted Aneurysm Analysis” pack-
age for their Allura 3D-RA, in use at a local hos-
pital. The curve shows actual diameter (in mm)
between the endpoints. The section of curve in
yellow indicates the stenosis. The point of great-
est deviation is marked. Location of aneurysms
is analogous.
5.7 Cranial arteries
For cranial arteries, a realistic curved section of artery was built in the computer-
aided design package Rhinoceros3D. See Figure 27. MRI data was obtained from a healthy
subject at risk for cranial aneurysms. An at-risk cranial artery was selected (posterior com-
municating artery). The artery lumen was approximated for a section of the artery, and a
centerline derived. The model’s geometry was built by lofting between proximal and distal
diameter measurements.
5.8 Geometry and mesh
There is high bending present at the neck of a saccular aneurysm, so I strive to
model tissues with an appropriately low bending stiffness. Also, my numerical method
should not introduce artificial bending stiffness. To that end, I choose to use a smaller
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number of larger elements, with higher degree basis functions. The increased degree in-
creases approximability; the large elements reduces effects due to incompressibility.
• one element in thickness direction (degree 3)
• large, high degree transversal elements (degree 3)
• very high Poisson ratio (.4999)
I used local refinement via hierarchical B-Splines [Evans 2015].
In building my analysis pipeline, I avoid very small aneurysms and very large
ones. I concentrate on common, moderately-sized aneurysms, away from bones or branches,
within a size range (2–7mm) dominated by physicians’ discretion regarding whether to
intervene. (See Figure 6.) These aneurysms are easy to identify from a CT scan. A stan-
dard technique is to measure the artery diameter’s variance from linear. (See Figure 26 on
page 98.)
Creating geometries is a crucial aspect of any image-to-computation suite. Pro-
fessional, nearly fully-automatic methods for locating aneurysms exist (see Figure 26), but
few of them allow extraction of the data in a computationally-ready format. Several groups
are working toward this end. Fully addressing registration and segmentation is not within
the scope of this work, however.
In this work, the aneurysm’s location is identified manually, from visual inspection
of the CT scan. I then use thresholding to segment the aneurysm and surrounding parent
artery.
5.9 Fiber directions
The geometric shape of the artery having been determined, the vector field of fiber
directions must be chosen.
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Fiber direction is not observable from current CT scanning techniques. I choose
a simple direction pattern based on a broad literature of biopsy studies and biomechanics
papers. These studies reveal that fiber direction varies in many ways:
1. Fibers lie in a helical pattern, pointing in symmetric directions with respect to the
artery axis.
2. It lies in the tangent plane (loosely speaking), which varies with position.
3. It follows motion and deformation of the artery [Baek 2006].
4. It is different depending on which coordinate system is being used.
5. There may be some dispersion of fibers.
6. At a given material point, new fibers are not necessarily placed along the grid lines
defined by the time t = 0 fiber directions. In fact, through deposition and reuptake, a
tissue reorients its fibers to align with directions of stress or strain [Humphrey 2000,
Kroon 2007]. In this case, new fibers will make a different angle with respect to the
axis than old fibers.
7. It can vary layer by layer, through the thickness of the artery [Kroon 2007].
8. Fibers build a network pattern through cross-linking.
Two additional observations investigated by researchers are
9. Fibers in humans are wavy when relaxed, not straight [Canham 1992, Smith 1981].
10. Fibers in humans are not all aligned perfectly, but have some distribution [Gasser 2012].
I choose two families of fibers pointing at ±45 degrees from the axis of the artery,
lying in the tangent plane. Each fiber acts as an independent, one-dimensional structure
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Figure 28: Choice of fiber directions. There are two families, oriented in the tangent plane, ±45
degrees from axial. The pink dot shows the location of the lesion.
which does not change its direction in material coordinates. Fiber directions are exactly
defined, with no dispersion or deposition/reuptake. See Figure 28.
The material is a continuum—fibers are not considered as individual proteins, but
are instead considered as densely packed within the artery wall. They are modeled as a
term within the material’s strain energy function 19.
This is a simple and effective choice based on the obervation that my model is not
very sensitive to fiber direction. Also, some of the observations above create complications;
for example, thickness-dependent orientations could introduce hard-to-interpret internal
stresses in the artery.
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Chapter 6
Results
I have created the first simulation of saccular aneurysm initiation and development from a
healthy artery geometry. Simulation results consistently show an aneurysm with a clearly-
defined neck. The simulation begins with a healthy artery; no localized change in thickness
is assumed, as in [Eriksson 2009].
The simulated aneurysm demonstrates behaviors similar to clinically-observed an-
eurysms: the diseased tissue becomes thin and distended from the parent artery, forming
a steadily-growing saccular aneurysm. My simulation gives insight into the mechanical
environment of aneurysms. I quantified forces and stresses experienced for a realistic an-
eurysm development. There are complex stress profiles within the neck region that include
both extension and compression. See Figure 34.
I began with a CT scan of a healthy subject who was potentially at risk for aneu-
rysm disease. I designed a realistic artery geometry from the CT scan. I selected a location
for a lesion likely to grow an aneurysm. I simulated an aneurysm from the lesion’s location
in multiple ways: first, by prescribing the deformation; second, by specifying an inelastic
strain rate. In each case, I quantified forces and stresses associated with the aneurysm.
The profiles of variables in the simulated etiology below provides a method for
researchers to understand saccular aneurysms within their own work. I begin such an
exploration in § 3.10.1 Alternative growth theories.
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I discovered that I can create saccular aneurysm geometries with existing consti-
tutive models. I also found my model of saccular aneurysm behavior is not very sensitive
to changes in the strain energy function
(
Equation (19)
)
or its material parameters. This is
surprising given a rich literature of novel contitutive models and lack of saccular aneurysm
results with these models. My model is sensitive to loading conditions, the size and shape
of the initial lesion, the rate at which inelastic strain proceeds, and the bending stiffness of
the tissue.
My model is consistent with clinical understanding of observed aneurysms. I ob-
serve
• significant stiffness difference between healthy and diseased tissue,
• huge strain in the aneurysm dome,
• complex stress patterns within the neck region during aneurysm initiation
– extension in the direction pointing around the neck’s circumference,
– compression in the direction pointing toward the center of the lesion,
• increased muscular contraction can maintain tone at the base of the aneurysm,
• small focal lesions can lead to large aneurysms.
These results show a successful method for simulating realistic geometries using
predictive modeling tools on top of existing constitutive arterial models.
I found that thin-walled arteries formed a saccular aneurysm along a wide range
of material parameters. The lesion was defined by local changes to Young’s modulus and
strain rate; a Winkler term was not used. By contrast, for realistic-thickness arteries only
a narrow range of material parameters formed saccular aneurysms. In this case the lesion
additionally required a Winkler term.
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Thin walls, a Winkler term, and reduced Young’s modulus all effect a lower bend-
ing stiffness. In my simulations, combinations of these led to saccular aneurysms, suggest-
ing bending stiffness is inversely related to likelihood of saccular aneurysm formation. I
suggest that future research and experiments quantify bending stiffness of artery tissue in
and around aneurysms.
6.1 Displacement-based calculations
In order to understand the time history of stresses in arteries, I built the capability
to perform a displacement-based calculation. This type of simulation allows the calcula-
tion of forces and stresses throughout the disease progression. By looking at this data, an
understanding of the environment that gives rise to aneurysms can be formed.
I created a realistic saccular aneurysm development from a healthy subject at risk
for an aneurysm.
My approach here is to simulate an aneurysm, where I prescribe the deformation
and compute the forces and stresses that result. This reveals time histories of parameters
which have the capability to produce saccular aneurysms. The model was investigated
and improved by changing values of material constants. I specified material parameters
as initial values for the forward problem. In this fashion, improvements were made to the
model so that the prescribed deformation induces physiologic stresses.
One-dimensional verification tests led to running test simulations of a straight
cylindrical artery with an axisymmetric lesion. See Figure 29. The lesion is a band in
the middle of the artery. The results led to observations that argued in favor of utilizing a
Winkler foundation force within my model.
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I used traction-based calculations in order to test the use of this Winkler foundation
to model external forces and other phenomena. Simulations have been performed with
axisymmetric lesions and with focal lesions.
A series of tests was run to explore a few aspects of the model. In the first test
(Figure 29a), a large lesion was postulated and a Winkler term was used. This simulation
produced the first successful computation of a saccular aneurysm.
In the second test (Figure 29c), no Winkler term was used. Notice the artery tissue
“slides” outward from the neck region. The forces involved are illustrated earlier in Fig-
ure 15 on page 46. The ends of the artery are fixed in place (a choice of boundary condition
which simplifies the calculation), so the artery buckles.
There is no support at the neck and a saccular aneurysm is not formed! Effects
like this may hinder Biomechanics simulations from creating a saccular aneurysms. This
phenomena illustrates an incomplete understanding of the forces and stresses at the neck
region, strength of tissue in the dome, and basal tone.
This is an axisymmetric lesion, and the lessons learned here apply to saccular an-
eurysms as well.
6.2 Problem setup for realistic artery calculations
I used an artery geometry created from the process in Chapter 5. In that process,
I began with the CT scan of a healthy subject, and finished with the smooth geometry
pictured in Figure 31 on page 110. I postulated a smooth lesion in the location of the
aneurysm.
I used the initial value problem of § 4.1. Boundary conditions are constant internal
blood pressure, a small or zero external pressure (modeled after the intracranial pressure
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and cerebral spinal fluid pressure in the brain), and clamped inlet and outlet (as in Fig-
ure 17). I used the adaptive constitutive model from § 3.8, and assumed the geometry was
initially stress-free. The stress-free geometry was loaded slowly by the boundary pressures,
before the lesion was applied.
6.3 Lesion specification for artery calculations
It is not known where surface area expansion (strain) occurs in saccular aneurysms.
It could occur broadly in the dome, focally in a region, or even in the ring-shaped region
of the neck. Most research indicates strain occurs focally where jets of blood flow impinge
on the aneurysm wall, and broadly within the dome otherwise. This is the assumption I
use for specifying lesions. I use a small-sized region for a lesion, because many saccular
aneurysms have narrow necks. These aneurysms are assumed to have formed from this
small region. (See Figure 31.)
The lesion location was defined as a small spherical region. Spatially, the lesion
is defined by two concentric spheres, where material outside them both is completely
healthy; material inside both is completely diseased; and material in between decays as
a C1 cubic function of space; see Figure 30a.
The temporal progression of disease is a scalar function. The artery starts com-
pletely healthy everywhere. After inflation, the lesion becomes gradually more diseased.
All of the rest of the artery is considered healthy at all times. The spatio-temporal
lesion is the product of the two functions; see Figure 30b.
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(a) Cubic decay function for defining the spatial location of the lesion. I define the lesion by two con-
centric spheres: The artery wall within the inner sphere is considered diseased tissue (blue); the artery
outside the outer sphere is healthy tissue (red); in between is a piecewise C1 smooth, cubic function.
(b) Example of a space-time function for defining a lesion. This example is the product of the spatial
function in (a) and a linearly-decaying function in time.
Figure 30: Cartoon describing the definition of a lesion for this work. In this cartoon, the lesion is
one-dimensional in space. (In an artery, the lesion is a three-dimensional function of space.) The
healthy region is colored red, the diseased region is blue.
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Figure 31: The dot indicates the postulated location of the postulated aneurysm, shown on the
healthy artery geometry. The top image shows the artery, the middle shows the lesion, and the
bottom image shows the local mesh refinement in the lesion region. (The facets in the image are to
highlight local mesh refinement. The geometry is G2 cubic, circumferentially and axially.)
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6.4 Material Parameters
The geometries were built as in §5.7 on page 98. The goal was to apply physiologic
forces to the model to grow saccular aneurysm geometries from healthy configurations.
The inlet and outlet of the artery were fixed in space, creating a boundary layer
that was far away from the lesion region.
Loading conditions were applied gradually, before the simulation was begun. This
consisted of blood pressure at 100 mmHg (internal loading) and cerebral spinal fluid pres-
sure (external loading) at amounts ranging from 0–10 mmHg, depending on the calcula-
tion. A full list of material parameters is seen in Table 32.
6.5 Growth-driven calculations
Using the passive growth models of § 3.7 was sufficient for simulating stable focal
lesions, but not for saccular aneurysms. An additional assumption was made: that the
pseudoelastic yield stress is not chosen a priori, but can be dependent upon the fiber stress
and growth rate.
In particular, I supposed the irreversible growth rate followed behaviors of ob-
served aneurysms. In an initially healthy thick-walled artery, I followed these stages, seen
in Figure 34:
1. The artery was inflated to normal pressures.
2. A lesion was initiated (reduced Young’s modulus and Winkler coefficient)..
3. Irreversible growth was initiated (λ˙ > 0, and σ/k increasing).1
1 The scalar σ = σ(x, t) is the (one-dimensional) Cauchy stress of collagen fibers. The scalar k = k(x, t) is the
pseudoelastic limit for those same fibers. Separate values (σ1, σ2, k1, k2) are used for fiber families 1, 2.
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material spring constant notes
radial artery dilation
during the cardiac cycle 600–900 g/s
2 [Wei 2012]
toy Slinky 840 g/s2 helical spring steel
Winkler term 0–66.67 kg/s2 thick, healthy tissue
car shock ∼5000 kg/s2
Table 33: Spring constants for various materials. These can be used to understand the size of the
Winkler term. I use a large Winkler stiffness for artery tissue with a thicker muscular layer, and near
zero Winkler stiffness for artery tissue with little or no muscular layer. Little medical data is available,
because in vivo material stiffness is difficult to measure.
4. Irreversible growth was slowed and stopped (σ/k decreasing).
5. Irreversible growth was re-initiated.
They mimic clinical observations for saccular aneurysms. In clinical terminology, I can
describe the steps as
1. A normal, healthy artery.
2. Disease processes are initiated by cellular changes in the artery wall.
3. A visible aneurysm begins to develop.
4. The aneurysm becomes stable. Most aneurysm diagnosis occurs at this stage.
5. The aneurysm becomes unstable. Around 10% of diagnosed saccular aneurysms go
unstable.
The final geometry for the thick-walled artery can bee seen in Figure 36. A cross
section shows the artery becomes thin in the aneurysmal region
(
Figure 37
)
. The healthy
artery is 0.15 mm thick (normal for the posterior communicating artery), and the aneu-
rysmal region is roughly 0.01 mm think. The neck is about one-third of a millimeter in
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Simulated Aneurysm
Figure 35: Simulation results for the thick-walled artery, showing relationships between k, σ, λirr,
and λ˙irr. (a) The top graph shows pseudoelastic limit k (black) and Cauchy stress σ (blue) of collagen
fibers. (b) The middle graph shows the stretch ratios. The purple curve λ is the product of the blue
curve λel and the red curve λirr. The elastic stretch λel is nearly 1 throughout and plays a negligible
role in aneurysm development; this is consistent with biological understanding of aneurysms. (c)
The bottom graph shows the time rate of change of λirr. This determines when the aneurysm grows.
The simulated aneurysm is shown cross-sectionally, with the proximal and distal artery cropped
from view. (The artery’s axis points into the page.) Notice from the images that the aneurysm grows
during those times when λ˙irr > 0 (early and late aneurysm images are shown), and not when λ˙irr = 0
(one image shown) which is true when the Cauchy stress is lower than the limit stress.
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Figure 38: Simulation for a thin-walled artery. Compared to the thick-walled simulation, Young’s
modulus was increased (see Table 32), and there was no Winkler term. The resulting aneurysm was
larger.
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diameter. The dome is roughly 1.14 mm wide (perpendicular to the artery axis), 0.84 mm
long (along the artery axis), and 0.90 mm in total height. The healthy Winkler coefficient
is 66.67 kg/s2, or 50 mm3Hg/mm. In the diseased region, it is reduced to a minimum of
0.3 mm3Hg/mm.2 The force exerted by the Winkler term is small: less than 20 mm3Hg
(equal to 0.0267 N).
I also performed a simulation with a thin-walled artery, to demonstrate the model
without a Winkler term. See Figure 38. In this case, Young’s modulus was higher to account
for the artery’s thinness; otherwise, material parameters and time-varying inputs were kept
the same.
6.6 Discussion
I developed a simulation tool for saccular aneurysms from common constitutive
models by adding two major features. First, I use local changes in material parameters to
represent weakening of the artery wall. Second, I use a growth model of adaptive irre-
versible strain to represent adverse collagen remodeling. Due to internal blood pressure,
these cause expansion and buckling of the arterial wall. The model is highly sensitive to
changes in material parameters related to these features.
My choices for parameters to define the lesion were motivated by kinematic argu-
ments. A saccular aneurysm deformation could not be achieved without localized changes
to some properties. For my simulations, I chose to reduce bending stiffness, to increase
lengths of collagen fibers, and add a Winkler foundation force in thick-walled arteries.
2 The unit mm3Hg is the force exerted by gravity of one cubic millimeter of mercury, equal to 1/7500.6 New-
tons. For example, a blood pressure of 120 mmHg on a 1 mm x 1 mm patch of artery exerts a force of 120 mm3Hg.
The unit mm3Hg/mm is a spring constant unit for a spring requiring one mm3Hg of force per millimeter of
displacement.
119
These local changes correspond to biological processes which are not fully understood.
Insight into biology can be gained by building biological models that conform to the kine-
matic requirements revealed by my work.
My observations suggest bending stiffness is a dominant factor in determining
whether a simulation forms a saccular aneurysm. Wall thickness, Young’s modulus, and
Winkler force all affect bending stiffness, and some combination of these was necessary
in all saccular aneurysm simulations I performed. Adaptive irreversible strain relies on
buckling of the artery wall, which is also dominated by bending stiffness.
On the biological side, bending stiffness is controlled by vascular tone, inflamma-
tion, and elastin degradation, among other factors. Tissue surface area enlargement is con-
trolled by changes in the collagen fiber network. Experiments can be devised to measure
these material responses and re-inform my kinematic simulations.
Particularly, better understanding of the strain rate for collagen growth λ˙irr and
elastin degradation k˙les can improve simulation results. These two variables in the model
line up neatly with stages of observed aneurysm development. My simulations have high-
lighted them as a path for biological and kinematic cross-communication.
The dome of the simulated aneurysm has a surface area of about four square mil-
limeters, from a lesion approximately one-third of a square millimeter. This is an increase
of area of factor of around 12. The thickness starts at 0.15mm and is simulated to thin
out to about 0.01mm. These are big changes for a tissue, and raise the question of what is
happening to the material physically to allow such a change.
My model considers the material as a continuum, and does not track individual
mechanisms of fiber strain. Those mechanisms could be: straightening of relaxed, wavy
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fibers; overstrain and breaking of fibers; remodeling of fibers; etc. None of these mecha-
nisms can be observed in vivo. Thus I cannot speculate on the physical changes a growing
aneurysm experiences, whether from experiment, observation, or simulation. I can say my
simulation shows enlargement profiles consistent with observations.
6.7 Suggested experiments
The profile of kles is a phenomenological model, capturing mechanical effects of
the phenomenon of degradation and aging. The analysis in Section § 3.8 describes how
to compute a profile of kles which, as I saw in this chapter, gives rise to a realistic saccu-
lar aneurysm. Thus kles has the capability to produce at least one class of saccular aneu-
rysm shapes. It may be the case that different kles profiles correspond to different lifestyle
choices. Future work will help ascertain the manner and extent of its capabilities.
Several interesting questions regarding kles immediately arise.
Question: Is kles rich enough to describe large classes of observed/observable data?
Question: If material properties are kept constant, could kles alone be enough to describe
the range of observable behavior?
Question: Is kles completely hidden from scrutiny, or is it measurable?
Question: How does changing features or properties of kles (such as time or space deriv-
atives) give rise to different classes of aneurysms? Put another way, can different
classes of aneurysms be usefully classified in terms of properties of kles?
Experiment: Could an experiment be run where material properties are kept the same, but
disease initiation (representing kles) is changed? Possible variables: age, sex, health
history (e.g., diabetes), lifestyle, smoking history, family history, artery tortuosity.
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Goal: Expand understanding of kles effects and its ability to grow a wide range of aneu-
rysm geometries.
6.8 Future work
This work demonstrates a process for simulating initiation and evolution of saccu-
lar aneurysms. Future projects could involve simulating different lesion shapes: circular
(used throughout Chapter 6) of various sizes, ring-shaped, a misshapen blob, circle-to-ring
(where growth occurrs in the neck region), circle-to-dome (where growth occurs only in the
dome), crescent; and differences through thickness (only outer layers, or only inner layers,
or more on inside or outside).
A membrane model could be devised from the current model. A membrane model
of fibers would display resistance to shear; my model displays resistance to shear via the
“background material.”
More attention can be paid to muscular and elastin degradation. Particularly, re-
search should investigate space-time profiles of degradation of muscle and elastin within
cranial arteries with age, including development of localized regions of degradation. The
localized degradation of artery walls is the main postulated initiator of disease in arterial
mechanics, but little published research attempts to give primary elastin degradation pro-
files. Most research postulates elastin degradation is secondary to another factor such as
wall shear stress, tortuosity, or a head injury.
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(a) Cartoon of a theoretical isolated lesion. Red is healthy; blue is diseased. Clear, simplified lesion functions like
this are interesting for basic research, but they miss nuances of irregular aging.
(b) Cartoon of a postulated realistic profile of elastin degradation in arteries. Color depicts health of elastin. Like
with skin, elastin in arteries degrades irregularly, with natural variations. It is likely that these natural variations
ultimately determine aneurysm locations.
Figure 39: Examples of elastin degradation and/or lesion profiles. Attention paid to experimental
measurements of these profiles will provide benefits to simulation and prediction.
Some researchers and clinicians suggest without proof that some people are born
with a propensity for localized degradation of arterial tissue.3 Autopsy studies should
quickly reveal whether this is the case.
There is no reason to believe degradation is constant in space, and natural variation
will certainly play a role in localized weakness and increased susceptibility to aneurysm
formation. Aneurysms are often thought of as single spots of diseased tissue within an
otherwise perfectly healthy artery, as in Figure 39a. Rather, they are more like Figure 39b.
To build better models of artery aging, one can study other similar tissues: skin and
arteries are layered tissues with collagen and elastin fibers—and skin is more observable.
Elastin degradation in aging skin shows similar patterns to elastin degradation in artery
3Aneurysms have been observed in uninjured adolescents and toddlers.
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walls. Degradation occurs, but not at constant rates. This is noticeable when focal skin
lesions occur (e.g., liver spots, freckles, cherry angioma, melanoma) There is variance in
the nature and extent of degradation; this variance can be measured experimentally, and
statistical distributions in both time and space can be built that faithfully model natural
aging processes. These space–time model of skin could be used to determine space–time
profiles for kles.
Patients with one cranial aneurysm are at high risk of having multiple aneurysms
[Mizoi 1989]. This suggests degradation is global; that is, degradation in one region im-
plies degradation in other regions. Assessing the manner and extent of degradation will
improve prediction of aneurysm disease. For instance, an important question to answer is,
does the variance and magnitude of degradation produced by the model comport with the
frequency and magnitude of formed aneurysms?
Experiment: For one or more subjects in the International Study of Unruptured Intracra-
nial Aneurysms [ISUIA 2003], perform an autopsy, including careful examination of
cerebral arteries. An analysis and quantification of artery tissue makeup (layers,
elastin degradation, muscular layer, collagen makeup, etc.) especially near aneu-
rysms and in apparently healthy tissue. Much can be learned from patients who do
not die of aneurysm-related illnesses.
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Chapter 7
Stages of aneurysm development
When connecting two disparate fields, we often want to answer questions posed in one
field with techniques built in the other. For example, questions in history such as “Did these
two cultures engage in trade?” can be satisfactorily answered by studies in anthropology:
“Do we find artifacts from both cultures in the same place?” Or perhaps photography can
help explain life’s struggles: a well-encapsulated image often elucidates and refines how
people think. In this work, I utilize techniques of kinematics to describe soft tissues, and to
understand initial stages of disease.
A person connecting fields should consider how to clarify the initial question to a
specific issue. It should also create an analogy between the fields that allows them to state
the clarified issue in terms of the second field. Techniques in the second field can be applied
in order to explain or solve the issue. The explanation should be able to be transferred back
into terms of the first field via the analogy linking the two fields.
For myself, I wanted to address intracranial aneurysms. Three major questions
arise when presented with a patient who has aneurysms: How did this aneurysm de-
velop? How will it progress in the future? And how can we prevent others from getting
aneurysms?
I have tried to answer the first question.
In so doing, I have clarified the question into specific issues, and created analogies
for translating understanding from medicine to engineering and back. I created a pipeline
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for building patient-specific geometric models of arteries from medical image data. I have
a tool for visualizing the simulated aneurysm to supplement physician understanding.
7.1 The Stages
My model is primarily driven by the relationship between two particular vari-
ables, pseudoelastic limit k and fiber stress σ. These quantities have important physical
interpretations. At each point in the artery wall, the fiber stress is the current stress felt by
the tissue. It represents the mechanical loading required of artery walls. The pseudoelas-
tic limit is the maximum stress the artery can experience without irreversible damage. It
represents a kind of maximum load limit for the artery.
This model of describing arteries is simple and has far-reaching implications. Prop-
erties of the difference of σ and k create natural descriptors for stages of aneurysm disease.
See Figure 41.
The progression in time of σ and k will vary, and they may cross each other. For a
healthy artery, k is bigger than σ. This is the situation for people who do not suffer from an
aneurysm. (Stage 0.)
In some people, k falls. It falls so far that it drops below σ. At this moment, an
aneurysm starts to form. (Stage 1 begins.)
The model has now created a rare and beautiful thing: a mathematical description
of a clinical finding. When k stays greater than σ, the artery appears healthy. When σ > k,
an aneurysm forms. (Stage 2.) In this case there is a visible aneurysm. For as long as σ > k,
the aneurysm will continue to enlarge.
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In most people with diagnosed aneurysms, the aneurysm is stable. Thus k must
have risen back above σ. (Stage 2.) There must be some healing mechanism. My model
dictates that k must be increasing for this to occur.
An immediate healing mechanism following a decay mechanism is consistent with
biological understanding. Biological mechanisms have competing pathways which bal-
ance. Immediately after an artery is injured, both clotting factors and anti-clotting factors
respond. A similar phenomenon occurs with cell depolarization: sodium channels open
to allow positive charge to rush into the cell, and potassium channels open to allow pos-
itive charge to rush out. In hormone replacement therapy, progestin is given to balance
estrogen. Pain stimulates analgesic responses.
In my model, I represent the dominance of healing by increasing k. When k in-
creases to become larger than σ, the aneurysm becomes stable. (Stage 3.)
Most aneurysms are diagnosed at this stage: they grew, but became stable.
An important question to be answered is whether the aneurysm will enlarge or
remain stable. Roughly ten percent do not remain stable. For these aneurysms, under my
model, k decays again below σ; in some cases, σ grows. I would like to be able to predict
which ninety percent will remain stable. These patients do not need annual followup scans,
which are both expensive and scary.
In the event of further enlargement, k will be less than σ again (back to Stage 2).
The aneurysm may enlarge slowly or quickly (Stage 2), may cause symptoms (Stage 4),
or may hemorrhage (Stage 5). A person experiencing symptoms often feels dizziness or
sudden, debilitating pain. Emergency surgery may be required.
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Stage
mathematical
description
of k− σ
clinical description
Stage 0 positive healthy artery
Stage 1 positive,decreasing preclinical lesion
Stage 2 negative growing (preclinical) aneurysm
Stage 3 was negative,now positive stable aneurysm
Stage 4 negative symptomatic aneurysm
Stage 5 negative hemorrhagic aneurysm
Table 40: Descriptions of stages. See also Figure 41.
Refined notions of health and disease emerge from the Stages. I can identify de-
cay of the artery as any time k is decreasing, or equivalently, when the derivative of k is
negative. Similarly, healing dominates when k increases. It may be appropriate to say heal-
ing processes also occur, but are not dominant, when k is concave upward. Under this
model, an aneurysm is enlarging if and only if k < σ. An aneurysm is stable if and only if
k > σ. I can answer many such questions from the connections between mathematics and
medicine. (See Figure 43 and Table 40.)
The aneurysm development I have just described is encapsulated in Figure 41. It
follows typical clinical presentation of aneurysms. Looking back over the aneurysm de-
velopment, I have built a direct analogy beween clinical findings and mathematical state-
ments. The analogy is compelling enough that I can suggest the search for a new clinical
finding: a “subclinical lesion”. Structural weakening within the artery wall probably be-
gins before deformation. The point at which this occurs significantly I can define as a
subclinical lesion. The artery appears healthy, but disease has already begun. Mathemat-
ically, I describe this as the point at which the pseudoelastic limit begins to fall markedly.
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In this case, the derivative of k is negative. It is at this stage that I hope to build preventive
treatment strategies to save lives, economic burden, and reduce disease. (See Figure 2.)
This concept is a valuable outcome of the biomechanical formulation built for the
current work. It recognizes two sensitive parameters in the model—pseudoelastic limit
and Cauchy stress—which dictate the progression of disease.
The results of my saccular aneurysm growth follows the same pattern, which can
been seen by drawing the Stages of Figure 41 upon the presentation of Figure 35. These are
combined in Figure 42.
7.2 Mathematical connection to clinical presentation
There are many interesting crossover concepts embedded within the graphic in
Figure 41.
For instance, a physician will ask, “Is this aneurysm stable?” The row of boxes in
the graphic show stability occurs in two regions: in Stages 0 and 1, and in Stage 3. These
stages are described mathematically as any time k < σ.
Similarly, the situation where k > σ implies an aneurysm is unstable—Stages 2, 4,
and 5. Other corresponding physician/mathematician questions are shown in Figure 43.
It leads to a necessary and sufficient condition:
Under this model,
an aneurysm is stable
if, and only if,
the pseudoelastic limit is larger than the Cauchy
stress.
Also:
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Stage 0 1 2 3 2 
growing
aneurysm
healthy
artery
sublicinial
lesion
stable
aneurysm
unstable
aneurysm
Simulated Aneurysm
Figure 42: Simulation data with Stages of aneurysm development. As predicted by the model, the
simulation results directly show a connection between mathematics driving the simulation and clin-
ical terminology. This figure is a combination of Figures 35 and 41. It shows that I have developed
a simulation tool which can predict realistic saccular aneurysm development from patient-specific
data—the first-ever model to do so.
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An aneurysm is present
if, and only if,
the Cauchy stress ever exceeded the pseudoelastic
limit.
Similar questions arise when asking, “What is a precursor to aneurysm disease?”
The answer, in this model, is “When the pseudoelastic limit first begins to fall.” Many
popular biomechanical models instead suggest that if there is no deformation, there is no
disease is present; that an artery’s disease state can be determined completely from the de-
formation. I have found a valuable connection to create a model which can model cellular
changes within an aneurysm wall. As the graphic indicates, I see a recognizable Stage of
subclinical lesion development which is a precursor to disease.
A subclinical lesion
in an apparently healthy artery
is a precursor to aneurysm disease.
In Medicine, it is accepted that there may be precursors to disease, but there is no
safe method to detect or measure them. The Stages graphic gives one: it suggests a direc-
tion for studying this precursor of disease. It suggests measurement of the pseudoelastic
limit and changes therein are methods for early detection and prevention of aneurysms.
The model provides summary concepts—pseudoelastic limit, fiber strength, sub-
clinical lesion—which biomechanical engineers and physicians can use to engage in an
ongoing dialog of alternatives. If the model is correct, it provides necessary and sufficient
conditions that bridge fields.
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The stages of aneurysm development shown in Figure 41 have shown promise.
They give a mathematical definition of clinical findings. They encourage conversations
between medical professionals and engineers researching tissue mechanics.
The next step is to continue those conversations. In this work, the stages will be
presented to clinicians and researchers. The concepts can be improved to encourage buy-
in from both fields. Buy-in from disparate parties is best achieved by engaging them in
the development process. Many avenues for connecting to physicians are discussed in
Chapter 8.
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Chapter 8
Cardiovascular Engineering at UT
Engagement of the medical community in cardiovascular engineering is well underway.
Ongoing long-term collaboration and access at institutions in Austin and Texas have been
developed. Hospitals, device companies, clinical practices, and the state government have
all been instrumental.
One of the most importnt aspects of connecting two major fields is arranging for
experts in each field to spend time in the environment of the other. For instance, Engi-
neering faculty and students need to learn some medicine, and experience medicine as it
is practiced by physicians. Physicians, for their part, need to take time from their practice
to learn how they approach problems.
Here at UT, I have done this in several ways: by offering Engineering graduate
courses in medicine, taught by physicians; by giving students access to hospital laborato-
ries and operating rooms; by joint Engineering–Medicine seminar series; and by offering
office space and resources to practicing physicians in Engineering buildings.
Crossover of engineers into hospitals needs to be a daily occurrence. At present, it
is a singular experience.
8.1 Cardiology courses at UT
Graduate-level courses dedicated to understanding and/or modeling of the car-
diovascular system are rare at UT.
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8.1.1 Clinical Cardiology
One of my first methods for engaging local physicians in engineering consultation
came from the creation of a seminar course in Mechanical Engineering, Clinical Cardiology,
taught by H Kent Beasley MD and myself. The course is now in its tenth year. It is wildly
popular. It features seminars from Kent Beasley, Noninvasive Cardiologist at Capital Medi-
cal Clinic for over 45 years (now retired), and nationally-renowned cardiologists from most
cardiac specialties: catheterization, electrophysiology, heart failure, robotic surgery, stem
cell therapy, vascular surgery, valve replacement, etc.
Presentations are designed to teach someone untrained in medicine about care and
treatment of cardiac patients. They are designed to engage the audience and stimulate new
ideas for how their interests can help improve treatment of heart disease.
Additionally, they allow physicians the chance to meet and collaborate with young
researchers on projects within the hospital. One of my students worked with a heart failure
specialist on evaluating so-called “left ventricular assist devices” (LVAD). LVADs are me-
chanical devices that aid a failing heart in pumping blood to the brain and body. The are
used in patients with heart failure, who might otherwise be candidates for a heart trans-
plant. Thus they are so-called “bridge-to-transplant” therapies.
LVADs are implanted in people both old and young. Many people over the age of
60 suffer from chronic heart failure and eventually need more help than medical therapy
can provide. Even some young people develop heart failure, frequently from a bacterial
infection destroying their valves.
Over a few decades of research, trials, and improvements, LVADs have become
effective therapies, giving patients a good quality of life. In fact, because LVADs are so
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effective, and because there are so few hearts available for transplant, many patients choose
to keep the LVAD as a permanent solution.
Heart transplants are serious endeavors: the initial surgery has risks, and a long
recovery period; 1-year survival rate is only about 88%; 5-year survival is about 70%; life
expectancy is 8.5 years. Medical management of transplant patients is challenging. Patients
become used to their LVAD, and many come to like it. Some patients remove themselves
from the transplant list. The LVAD becomes an “end of life” therapy.
One such person comes each year to speak to the class. He is now about 40 years
old.1 As a young man in his low thirties, he was suddenly diagnosed with heart failure.
Unbenownst to him, he had had a bacterial infection which degraded his tricuspid valve
completely. Regurgitation naturally followed and his heart overworked itself attempting
to maintain blood flow. It quickly gave out.
He was a strong candidate for a transplantable heart. He had an LVAD placed as
a “bridge to transpant” therapy. Physicians expected it to last 3–5 years. His physicians’
mean wait time for a heart was eighteen months. He was sure to receive a new heart.
But he did not. After two years of living with his LVAD, no compatible hearts had
appeared. By then he had found a comfortable routine. He was able to wash himself just
fine, stay active, keep a job, and he had a good quality of life.
He chose to remove himself from the transplant list. The drawbacks of an LVAD
were acceptable to him, and he no longer wanted to take on the drawbacks of a trans-
planted heart. He has had an LVAD for about 8 years. It shows no signs of stopping! It is a
1 Some details have been changed.
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deeply emotional discussion to interact with someone who has chosen to let the success or
failure of a mechanical device determine how long and how well they live.
It is also heartwarming to hear that such a device exists. We should invent more:
improved management of heart failure patients is crucial to the future of healthcare. Heart
failure is the most important cardiovascular issue to be solved today [Carpentier 2007].
The long-term care of a heart failure patient is challenging. A patient will typically
see a heart failure specialist once or twice per year; and also and also be hospitalized with
an acute condition once or twice per year; and also their primary care physician must
consider their heart failure in every diagnosis and treatment, no matter now mundane.
As the number of heart failure patients grows this creates a huge demand for predictive
treatment strategies of all types, not just for LVADs.
Figure 44: Forward surgical team in Asia prepares
for a mission, 2011. Photo by U.S. Air Force Senior
Airman Cassandra Locke [Locke 2011].
Another guest speaker each year
is a surgeon who speaks on his specialty,
vascular hemodynamics, and also his three
voluntary tours of duty in Germany as
a military surgeon treating fresh battle
wounds from soldiers fighting in Iraq and
Afghanistan. It’s a surprise to go to Ger-
many to operate on soldiers wounded in
the Middle East. It means that some pre-
sumably intelligent, well educated military administrator decided it would be a good idea
to station the battlefield surgery team seven thousand miles away from the battlefield!
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In fact, it’s a brilliant idea that has saved thousands of lives. Twenty battlefield
medics travel in humvees, directly behind battlefield lines, and set up a 900-square-foot
hospital facility with four ventilator-equipped recovery beds and two operating tables.
They can go from driving to open surgery in less than an hour. The teams travel as light
as possible. For instance, they do not use an x-ray machine. Broken bones are detected by
feel.
They stabilize wounded as quickly as possible—in under two hours—and imme-
diately ship them out—often still anesthetized—to the next medical team at the next level
of care. Anyone requiring more than three days’ treatment goes to Germany, anyone re-
quiring more than thirty days goes to Walter Reed or San Antonio. Once the system was in
full swing, the average time to reach Germany was two days, the U.S. in less than four.
Figure 45: Forward surgical team in Kuwait,
2005. Two intensive care recovery beds are shown.
Photo courtesy U.S. Army Captain Herman Alli-
son [Allison 2005].
It’s similar to the idea of arriving at
a hospital and going first to the Emergency
Room, then the Intensive Care Unit, and
then to a bed on a floor. Except they’re ten
thousand miles apart, and the Emergency
Room follows you around.
The novelty of the idea lies in sep-
arating the necessary surgery into separate
surgeries. The main surgery team needs
too much equipment and support to be
close to the battlefield. The battlefield surgeon’s role is only to stabilize the patient. He
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doesn’t even try to finish the surgery. Yet both surgical teams have to work in harmony
with very little patient workup. This is a huge change from typical Western healthcare.
To see how it’s worked, consider that in each of the Korean War, the Vietnam War,
and the Gulf War, we saved 75% of wounded US soldiers. In Iraq and Afghanistan, we
saved 90%.
None of this required new technology: nothing more than aggressive first-line
treatment within five minutes, and a trust that the team at the next level can care for your
patient as well as you, has saved ten thousand lives.
Many issues arose, some of them perfect for a Cardiovascular Engineering design
team. Perhaps due to the lengthy air travel, there were high rates of pulmonary embolism
and deep vein thrombosis. Five percent of the soldiers who went to Walter Reed contracted
a pulmonary embolism. Engineers could design a new inferior vena cava filter, and per-
haps eliminate this issue. [Gawande 2004]
These teams travel light. Software is light. What can computational medicine pro-
vide for acute care? This actually raises an important observation. Most predictive com-
putational medicine is designed around chronic conditions. The fields of acute care and
especially emergency care are ripe for predictive modeling.
8.1.2 Pathophysiology and Epidemiology of Cardiovascular Disease
Another course developed was Pathophysiology and Epidemiology of Cardiovascular
Disease, taught by Tate Erlinger MD and myself. The course was taught from 2006 to 2013.
Dr. Erlinger is Medical Director at Seton Health Alliance and Vice President of Clinical Ef-
fectiveness and Care Redesign within the Center for Experience and Effectiveness. While
teaching the course, he was also formerly Director of Research Administration Infection
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Prevention & Epidemiology at Seton Family of Hospitals, Chief Medical Officer for a local
health insurance agency, and State Epidemiologist for Texas Department of State Health
Services.The course appeals to engineers, kinesiologists, and nurses. It provides insight
into the assessment of cardiovascular disease, reading studies published in medical litera-
ture, and understanding ways of effectively introducing technology into medical practice.
An example is illustrative.
There were many studies—such as [Illingworth 2000]—which pharmaceutical com-
panies used to argue massive overindulgence in statin use. This meta-study seems to
show lower LDL indicates lower coronary heart disease (CHD) risk, which had already
been established as true. Pharmaceutical companies argue low density lipoprotein (LDL)
levels should be pushed as low as possible, because no minimum safe level of LDL has
been observed, and patients naturally want the lowest CHD risk possible. Statins are
well-tolerated, have comparatively few side effects, and they seem not to have many neg-
ative interactions with other medications. Pharmaceutical companies aggressively push
increased statin dosage.
But none of the studies showed that increasing dosage had increased benefit. They
only showed getting a nominal dose was better than getting no dose; and that people
whose LDL happened to be lower had fewer CHD events. There is no reason to think LDL
levels should be a target. The treatment guidelines said that if LDL was above a certain
amount, giving a statin was shown to have benefit. The treatment guidelines did not say
that if LDL was above a certain amount, giving enough drugs to push the LDL level down as
far as possible was shown to have benefit.
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The meta-analysis statin manufacturers used is an observational study. Study sub-
jects weren’t randomized to pre-determined LDL values; they were randomized to a given
statin dosage. So we can only say for certain that statins are better than placebo at lower-
ing risk. But we never ran the study of randomizing people to achieve certain LDL values
(regardless of how much exercise or how much dosage it took to get there). And until we
do, the guidelines will only be to give a statin based on reducing overall CVD risk.
Certain study subjects may have achieved lower LDL levels, and also had better
outcomes, and that correlation may have been compelling; but we did not confirm that
causing the LDL to go lower than what the subject happened to have achieved would
continue to improve that subject’s outcome.
None of the studies targeted LDL and pushed their patients to a certain LDL level.
None of the studies said to keep driving patients’ LDL levels down further and further.
But that’s what physicians did. That’s what drug salesmen harangued physicians to do.
According to misinterpreted findings and aggressive advice, many physicians increased
statin dosage until patients reached certain LDL targets.
This is not an unreasonable mistake to make. Comparisons of LDL and CHD show
LDL distributions of people with and without CHD are surprisingly similar [Castelli 1996].
Also, there is increased risk of CHD with higher levels of LDL [Martin 1996]. There is an
exponential increase in risk, even at low levels of risk. No matter what one’s LDL level
was, or how much it had been treated, it seems that lowering further is always better.
And federal policies inadvertently promoted this kind of thinking. Lowering the nation’s
average cholesterol level became a priority, one that saved tens of thousands of lives per
year.
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An overly-aggressive interpretation was so pervasive that in 2013, the new recom-
mendations by the National Heart, Lung, and Blood Institute were released, ATP IV. It
reminded everyone not to lose sight of the proper target: ten-year risk. ATP IV reminded
physicians not to move LDL to certain targets, but to use statins—as only one part of an
entire treatment plan—in order to minimize ten-year risk of heart attack, according to a
certain reasonable formula. That is, physicians should treat patients to control their level
of cardiovascular risk, based upon an estimated 10-year risk or a lifetime risk of cardiovas-
cular disease.
In fact, The New York Times went further: they pointed out that the usual non-drug
LDL-lowering therapies—diet, exercise even in small amounts, stopping smoking—remain
superior to drug therapies [Abramson 2013]. Where is the billion-dollar industry behind
these treatments? Why do health insurers ignore them?
In the class, I give students an understanding of clinical trials and what they ac-
tually tell us, so they can avoid this kind of mistake. When we understand how health
indicators are measured, we can understand how to improve them.
I discuss gaps in measurement technology. For example, I do not have a model for
how the placenta works! Fetal heart rate is the only measurement of overall fetal health.
There is no noninvasive way to measure blood pressure of a fetus, nor any measure of
blood nutrients. Consider that pregnancy is the single most common reason for admission
to a hospital, and that blood pressure is by far the single most commonly measured indi-
cator of health. A good computer model for placenta would be an overnight billion-dollar
industry.
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8.1.3 Cardiovascular Dynamics
This course, ME 385J topic 5, emphasized the design and application of electrical
and mechanical devices for cardiac intervention. It has not been offered in over fifteen
years. It would be an excellent followup to Clinical Cardiology.
8.1.4 Hospital Interfaces
ME 385J topic 11, was taught by Thomas Runge MD, who held a Clinical Profes-
sorship in the School of Engineering and was the first cardiologist in Austin. His class
was the first course in the country to give graduate Biomechanical Engineering students
at chance to observe everyday workings of hospital laboratories. Students would shadow
Dr. Runge and other physicians on their rounds at a local hospital. While demonstrating
hospital life and introducing students to patients and letting them share their stories, he
explained medicine from a healthcare perspective. (Clinical Cardiology explains medicine
from a surgical or interventional perspective.) Among other topics, he discussed the en-
gineering implications of providing electricity, clean water, breathable gases, wastewater
removal, and sterilization for a large hospital. The scalability requirements and the life-
threatening prospect of less than 99.9% uptime of utilities is a modern day accomplishment.
[Baker 2008]
This was done at the nearby Brackenridge hospital, a central Austin trauma center.
Future courses could be developed at Brackenridge, the new Dell Medical Center, or at
Heart Hospital of Austin.
144
8.2 Faculty and student access to observe medical procedures
Following in the footsteps of Hospital Interfaces, the Department of Mechanical En-
gineering and the Institute for Computational Engineering and Sciences at UT have devel-
oped additional means for teaching Engineers the day-by-day vagaries of healthcare.
The programs have been folded into the courses described above, but they are
important and difficult to create and maintain, and they deserve additional discussion.
Until UT’s School of Engineering sets up an official long-term contract with the two nearby
hospital systems, there will be barriers to student engineers collaborating with physicians.
8.2.1 Preceptorship at Heart Hospital of Austin
A second important feature of the Clinical Cardiology course is the establishment
of a preceptorship at Heart Hospital of Austin, a campus of St. David’s Medical Center.
Thanks to the efforts of Kent Beasley, myself, and many others, students are able to visit
the Heart Hospital to observe surgical procedures such as catheterization, cardiac bypass,
and robotic surgery.
This is an ongoing opportunity that has developed a collegial environment whereby
practicing physicians are aware of engineering research, educated in various ongoing proj-
ects, and interested in assisting. A friendly, collaborative atmosphere is crucial to success.
The preceptorship is enabled through an agreement with St. David’s HealthCare.
Students are allowed to visit the hospital for up to 8 hours.
Ideally, The University of Texas at Austin and St. David’s HealthCare would cre-
ate a long-term institutional agreement to allow student observers. However, when St.
David’s HealthCare bought Heart Hospital of Austin, St. David’s asked UT to sign an
onerous boilerplate contract meant for student visitors who participate in patient care—
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e.g., nursing students who perform blood draws. UT rejected the contract, putting the
course in jeopardy. Subsequently, ICES and Dr. Beasley went to great effort to achieve a
tentative agreement from UT and St. David’s representatives to draw up an appropriate
contract.
8.2.2 Cardiology rounds at Brackenridge Hospital
In order to learn cardiology, I followed physicians on rounds at Brackenridge Hos-
pital as part of the Residency Program at The University of Texas Medical Branch, partic-
ularly under David W. Hayes MD, Chief of Staff at University Medical Center at Bracken-
ridge. It was an opportunity similar in nature to the Hospital Interfaces course mentioned
above. On these rounds, I went through case studies, visited with patients, observed stress
echocardiography, read EKGs, and observed surgical procedures. I saw many common
hospital Primarily, I helped set up a pathway for other engineering students and professors
to learn clinical cardiology. That pathway led to Clinical Cardiology and the Heart Hospital
of Austin preceptorship.
8.3 Physician access to engineering research
Face time spent between engineers and physicians is crucial to joint success. As
engineers, we need to be creative to find ways to encourage physicians to spend time away
from their practice working on long-term projects. This is especially true as it is logistically
difficult and time-consuming for visitors to enter campus.
8.3.1 Seminar series
There are a few ongoing seminar series devoted to connecting engineers with
physicians. One of these is the Computational Medicine Spring Lecture Series, in its first
146
year [ICES 2015]. Seminars are presented by engineering professors and attended by both
academics and local physicians. In coming seminars, physicians will present seminars on
medical care and issues that can be addressed by engineering technologies.
These seminars are distinct from Clinical Cardiology seminars, in that the thurst is
to bring the application of computational medicine closer to clinical practice. It highlights
emerging or longstanding issues in clinical care, and facilitates discussion of research di-
rections for addressing these issues.
Another important aspect of the seminars is it brings engineers and physicians
together in ongoing discussions of medicine and engineering. Seeds from such discussions
grow into improved healthcare.
8.3.2 Continuing Medical Education
One way to provide value for physicians is through Continuing Medical Education
(CME). CME is a process by which physicians learn new techinques and stay current with
medical developments. Many states (including Texas) require CME for physicians to main-
tain licensure. The University of Texas at Austin – University Health Services is accredited
by Texas Medical Association to provide CME. University Health Services could work with
the Institute for Computational Engineering and Sciences so that Computational Medicine
seminars provide CMEs for attendees. There could be dedicated CME seminars presenting
engineering advancements in medicine.
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Chapter 9
Conclusions
The biggest challenge to simulating behavior of tissues (or any phenomenon) is and always
will be modeling. Researchers must determine relevant behavior, create constitutive laws
to describe that behavior, establish conditions under which the laws are valid, and assess
the manner and extent of their validity. Knowing how a given tissue behaves and knowing
ways in which these behaviors can be represented in Biomechanical theory is the primary
focus of every modeler.
This work fills three roles that meet this challenge: it is intended as an improve-
ment over current best practices in arterial modeling; as a means for combining the entire
image data–to–simulation pathway; and for building a viable parameter space.
I have also worked to connect engineers with physicians to improve healthcare
strategies. The Stages concept in this work provides a common language with which
biomechanical engineers can communicate with physicians. Using the model, questions
in one field can be translated into equivalent questions in another. This work serves as a
new strategy to improve early detection and treatment of aneurysms.
Computer simulation can provide improved medical treatment if stakeholders
from all relevant fields work together to build a multidisciplinary framework to discover
solutions. I have provided a bridge between fields. Through direct results and their in-
evitable application to other areas, continued work in this area will have an impact on the
biomechanical literature and medical practice.
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I created a pipeline of tools for simulations, using patient-specific geometries from
medical image data. I constructed novel constitutive models for fiber behavior. I have built
the first simulation of saccular aneurysm initiation and enlargement from a healthy artery.
I identified stages of aneurysm disease that connect clinical findings with mathematical
relations. I identified sensitive parameters within the model which explain the model’s
behavior. I used these findings to propose novel experiments which can explore the disease
process to help determine risk of aneurysm enlargement.
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Description of Symbols and Abbreviations
B material body
∂B boundary of B
C elasticity tensor
χA(x) characteristic function on the set A
∂
∂t |X material derivative
δij delta function; δij = 1 if i = j, 0 otherwise
E Young’s modulus
g(X, t) essential boundary condition, applied to Γinlet and Γoutlet
Γg domain of essential boundary conditions (in the reference system); the material’s
position is prescribed on this boundary; Γg = Γinlet ∪ Γoutlet
Γh domain where the natural boundary conditions are applied (in the reference sys-
tem); external pressures are prescribed on this boundary; Γh = Γinterior ∪ Γexterior
h(X, t) natural boundary condition, applied to Γinterior and Γexterior
H1(Ω0) Sobolev space
J ratio of current volume to reference volume; J(X, t) = det F(X, t)
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k-fiber: fiber from family k = 1, 2; the distinction between the two fiber families is the
directions in which they point; the families are otherwise treated identically
Kg growth constant; Kg ∈ [0, 1] [Baek 2006]
λk(τ, t) stretch at time t of k-fibers placed at time τ
mk(τ, t) orientation at time t of k-fibers placed at time τ
N outward-pointing unit normal in the reference configuration
NA NURBS basis functions comprising Vh and Sh
ν Poisson’s ratio
Ω0 set of X in B at time 0
Ωt set of x in B at time t
pBP average blood pressure, constant at GNR timescale, applied to Γinterior
pbrain pressure boundary condition on the exterior of the artery; derived from intracra-
nial pressure and cerebrospinal fluid pressure; constant at all timescales, applied to
Γexterior
ϕt material motion
q(X, t) Winkler stiffness coefficient
q(τ) decay function representing the uptake of old fibers in remodeling
R rate of growth; r dv = R dV
Relastin initial fraction of all the non-growing constituents of the material
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Rk initial fraction of constituent k
rk(τ) scalar measure of stress-induced growth in the direction of k-fibers
r rate of growth; r = r(x, t); d/dt (dm) = r dv
rh homeostatic mass production; this represents the mass production rate required of
a healthy artery to remain stable
RAi residual in the i-th direction at node A for use in solving (GNR, G)
 restriction of a function to a smaller domain
ρ current mass density per unit current volume; this number is assumed constant for
all time, for all points in the body
S “space” of candidate solutions
Sh finite-dimensional approximation of S
σk(τ) (scalar-valued) component of FSI stress that would be felt by k-fibers
σcardiac(τ): Cauchy stress form of Scardiac
σh homeostatic stress; this represents the body’s (postulated) target stress level; J.D.
Humphrey believes σh is approximately 100kPa
t time
∆t timestep
V space of test functions
Vh finite-dimensional approximation of V
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w(t): strain energy density function; w(t) = w(X, t)
x point in current configuration
X point in reference configuration
AAA abdominal aortic aneurysm
ACA anterior communicating artery
aneurysm: bulge in the wall of an artery or vein
apoptosis: /apo·TOE·sis/ a highly-regulated biological process of programmed cell death;
the opposite of apoptosis—unregulated cell proliferation—is cancer
ATP Adult Treatment Panel
ATP IV: Adult Treatment Panel’s fourth and current set of guidelines for treatment of dis-
ease in adults
CHD coronary heart disease
CME Continuing Medical Education
CT x-ray computed tomography
CVD cardiovascular disease
EKG electrocardiograph
GNR growth and remodeling
growth: addition of mass, independent of deformation
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IMT intima–media thickness
IRB Internal Review Board
ISUIA International Study of Unruptured Intracranial Aneurysms
JL4 Judkins 4 catheter for accessing left coronary artery
LAD left anterior descending artery
LCA left coronary artery
LCX left circumflex artery
LDL low density lipoprotein, aka bad cholesterol
LVAD left ventricular assist device; a mechanical aid for a failing heart
LVAD left ventricular assist device
MR magnetic resonance imaging
MRFIT Multiple Risk Factor Intervention Trial
MRI magnetic resonance imaging
PCommA: posterior communicating artery
PET positron emission tomography
QRS complex: waves on an EKG which represent ventricular contraction
Ramos branch: branch artery arising at the juncture of the LCX and LAD; the Ramos branch
serves the same purpose as diagonal branches off the LCX or LAD
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RCA right coronary artery
remodeling: changes in structure due to replacement of old material (fibers, in this work)
with new material
SPECT single photon emission computed tomography
subclinical lesion: structural weakening within an artery that leads to aneurysm or may
lead to aneurysm
tricuspid valve: heart valve in mammals that regulates blood flow from the right atrium
to the right ventricle; this is blood traveling from the body into the lungs
UT The University of Texas at Austin
WSS wall shear stress
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boundary value problem (BVP)
growth and remodeling
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bridge to transplant therapy
LVAD as, 136
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c1, 35, 112
c2, 35, 112
candidate solutions (S), 30
cardiovascular disease (CVD), 142
catheterization, 7
Circle of Willis, 8
collagen, 16
collagen turnover, 18
computed tomography
single photon emission (SPECT), 85
computed tomography (CT), 7, 83
Continuing Medical Education, 147
coronary heart disease (CHD), 141
D
decay, 3
density (ρ), 112
disease
aneurysm, 7
cardiovascular (CVD), 142
coronary heart (CHD), 141
E
E, 44, 112
elasticity tensor (C), 37
electrocardiograph (EKG), 87
end of life therapy
LVAD as, 137
enlargement, 18
F
F, 25
fiber reorientation, 17
fibers
transversely isotropic, 17
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fusiform aneurysm, 8
G
g(X, t), 29
growth, 3, 18
growth and remodeling (GNR)
boundary value problem
strong form, 28–30
weak form, 30, 31
strain energy function
membrane, 19
H
h(X, t), 29
Hirr, 38, 41, 112
Hles, 38, 40, 112
heart disease
coronary (CHD), 141
heart failure
chronic, 136
homeostatic stress, 16
I
imaging
computed tomography (CT), 83
magnetic resonance (MRI), 83, 86
positron emission tomography (PET),
82
single photon emission computed to-
mography (SPECT), 85
ultrasound, 83
intima–media thickness, 112
ISUIA, 124
J
J, 30
K
k-fiber, 34, 46
L
λk(τ, t), 47
left anterior descending artery (LAD), 96,
97
left circumflex artery (LCX), 97
left coronary artery (LCA), 97
left ventricular assist device (LVAD), 136
as bridge to transplant therapy, 136
as end of life therapy, 137
lesion size, 112
lipoprotein
low density (LDL), 141–143
long timescale, 19
low density lipoprotein (LDL), 141–143
M
mk(τ, t), 47–49
magnetic resonance imaging (MRI), 7, 83,
86
model, 81
modeling
subject-specific, 91, 97, see also mod-
eling, patient-specific
modeling pipeline, 81
N
N, 30
NA, 61
ν, 112
O
Ω0, 22
Ωt, 22
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PpBP, 28, 29, 61, 112
pbrain, 28, 29, 61, 112
ϕt, 22
pipeline, 81
Poisson’s ratio (ν), 112
positron emission tomography (PET), 82
posterior communicating artery (PCommA),
98, 112
pre-stretch, 16
Q
q, 112
q(τ), 49
q(X, t), 44
QRS complex, 87
quasi-static, 28
R
r, 22–27, 29, 61
rk(τ), 49
Relastin, 49
ρ, 23, 112
RAi , 62
rapid prototyping,
residual (RAi ), 62
reuptake, see turnover of constituents
right coronary artery (RCA), 97
S
S, 37
S, 30
Sh, 61
Scardiac, 20, 52
SFSI, 20
saccular aneurysm, 8
Second Piola–Kirchhoff stress tensor (S),
37
short timescale, 19
single photon emission computed tomog-
raphy (SPECT), 85
Slinky, 113
strain energy function, 33, 47
for fibrous material, 18
growth and remodeling
membrane, 19
subclinical lesion, 128
subject-specific modeling, 91, 97, see also
patient-specific modeling
T
∆t, 64, 66, 67, 112
τrelax, 64, 66, 67, 112
test function space (V), 30
therapy
bridge to transplant, 136
end of life, 137
timescale
long, 19
short, 19
tomography
positron emission (PET), 82
single photon emission computed (SPECT),
85
x-ray computed (CT), 83
tone, 43
transversely isotropic fibers, 17
tricuspid valve, 137
turnover of collagen, 18
U
ultrasound imaging, 83
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VV, 30
Vh, 61
vascular tone, 43
visualization, 81
W
Wk(τ, t), 46–48
Winkler foundation, 44
Winkler stiffness (q), 112
Y
Young’s modulus (E), 44, 112
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